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Attention was first drawn to muscular weakness as a symptom
of thyrotoxicosis by Graves (1935) and Basedow (1840). However,
it was not until 1885 that Du Cazal presented a patient with the
simultaneous onset of thyrotoxicosis and severe muscle atrophy
(Sattler 1952). Ten years later, in 1895, Burthurst described
"A case of Graves* Disease Associated with Idiopathic Musoular
Atrophy", which concerned a man aged 20 who complained of diffi¬
culty in walking and of generalised musoular weakness for 14
months. He had the typical features of thyrotoxicosis, with
exophthalmos and moderate enlargement of the thyroid gland, but
in addition he had wasting and weakness of the deltoid muscles,
biceps brachii, thenar eminences and the gluteal muscles and there
was weakness of the serratus anterior. One of the most character¬
istic features of his weakness was that he was unable to raise
himself from the lying or kneeling positions without using his
arms.
Since Du Cazal wrote the first report 73 further cases of
definite marked muscular atrophy in hyperthyroidism have been
recorded in the literature (for references see Table 1) and the
condition was first referred to by MacKenzie (1940) as "chronic
thyrotoxic myopathy".
Since 1894, when Miiller reported 4 thyrotoxic patients with
nasal speech and dysphagia and one patient with hallucinations,
many different types of neuro-muscular disorder associated with
hyperthyroidism have been described. These have been classified
by Logothetis in a recent review article (1961) and are presented
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here in a slightly modified form;
A. Myopathies resulting from hyperthyroidism
1. Acute thyrotoxic myopathy
2. Chronic thyrotoxic myopathy
3. Endocrine ophthalmoplegia
B. %opathies sometimes associated with hyperthyroidism
1. Myasthenia Gravis
2. Periodic Paralysis
C. Neurological manifestations in thyrotoxicosis
1. Acute thyrotoxic "enoephalomyopathy"
2. Optic nerve lesions and retinopathy
3. Thyrotoxic crisis and coma
4. Upper motor neurone syndromes
5. Thyrotoxic eleotroeortical dysrhythmia and
seizures
6. Thyrotoxic tremor and chorea
7. Parkinsonism in thyrotoxicosis
D. Psychiatric manifestations in hyperthyroidism
This discussion will he confined to the various muscular com¬
plications which are associated with thyrotoxicosis.
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Acute Thyrotoxic Myopathy and Kr ceohalomyopathy
These two are being considered together because many authors
describe the same clinical findings under either heading. The
first papers in the English literature on the acute paresis of
thyrotoxicosis were by Laurent (1944), Waldenstrom (1945)» Sheldon
and Walker (1946) and Strong (1949). However, Waldenstrom, in
addition to describing his own 10 cases, quoted a large number of
patients with similar features whioh had been culled mainly from
the German literature of the previous 50 years. The clinical
pioture was of the sudden onset of bulbar palsy in a patient who
may have had antecedent thyrotoxic symptoms for several months or
even years. In many of the cases cited by Waldenstrom (1945)
there was severe diarrhoea and vomiting and also clear evidence of
thyrotoxic crisis and ooma, and this latter association has been
desoribed in subsequent case reports (Chapman and Maloof 1956,
Gimlette 1959, Heinrich, KcCabe, Nicely and Elder 1962). Eight
out of 10 of Waldenstrom's patients had atrial fibrillation.
Other features which have been noted are aching in the limbs and
paraesthesiae (Gimlette 1959). 3h most of the articles which
have been written since 1945 the authors have indicated that there
was generalised muscle weakness in addition to the ptosis, diffi¬
culty with speech, dysphagia and the nasal regurgitation of fluids,
though ophthalmoplegia does not seem to have been a prominent
feature. The tendon reflexes were variable, being reported as
brisk or totally absent, and in one case there was evidence of an
upper motor neurone lesion (Heinrioh et al. 1962). Sanghvi,
Gupta, Banerjee and Bose (1959) desoribed the acute onset of
paraplegia, hypokalaemia and nephropathy in a thyrotoxic patient
in whom the paralysis showed no response to treatment with
potassium but was completely cured by thyroidectomy.
Fasciculation was seen in Heinrich et al,'s oase and
fibrillation was reported in the shoulder muscles of Strong's
(1949) patient, but, since fibrillation consists of the contrac¬
tion of individual muscle fibres and is not visible through the
skin (Thomas 1963, P« 315) it is suggested that the spontaneous
activity seen in this patient was possibly fasoiculation or even
myokymia (see p. 21 ).
Pathological reports are scanty, but in WaldenstrSm's
review an enlarged thymus was noted on three occasions and
degeneration and haemorrhage into the oranial nerve nuclei in
three oases, ft Lcfoscopic examination of the brain in Chapman and
Maloof's (1956) second patient revealed slight to moderate swel¬
ling of oligodendroglia in the suboortioal white matter. Muscle
histology has been commented on three times. Strong (1949) found
only evidenoe of oedema in biopsies of ocular and temporal musoles,
whereas Gimlette's (1959) first case showed widespread degenera¬
tion of muscle fibres with fooi of lymphocytes and Sanghvi et al.
(1959) found evidence of fibre degeneration with vacuolisation,
saroolemmal nuolear proliferation and loss of striations in swollen
fibres.
Electromyography appears to have been done on only two
ocoasions and in both patients the pattern was that of a myopathy
(Gimlette 1959).
A fatal outcome was almost the rule in the earlier cases,
but Waldenstrom (1945) was able to obtain a full remission of
symptoms using iodine followed by partial thyroidectomy. Later,
with the development of effective antithyroid drugs and radio¬
active iodine, complete recovery has been obtained with medical
treatment (Strong 1949, Chapman and Maloof 1956, Gimlette 1959,
Heinrich et al. 1962), thus tending to disprove Waldenstrom's
(1945) theory that the condition was caused by a lack of iodine.
The objection has been raised by Millikan and Haines (1953)
that many of the earlier cases described in the literature may
have been myasthenia gravis coincident with thyrotoxicosis, but
is difficult to prove or disprove their contention. However,
neostigmine gave dramatic relief from the bulbar symptoms in three
of the more recent cases (Laurent 1944, Sheldon and Walker 1946).
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Chronic Thyrotoxic Myopathy
Clinical Features. Seventy-three cases of chronic thyrotoxic
myopathy have been reported in the literature (see Table 1).
Melville (1959) doubted whether the term "chronic" should be
applied since many of the oases had a history of only about 9
months' duration. However, an analysis of the cases shows that
the mean duration of the myopathy was 11.1 months in men and 16.7
months in women, so the description seems quite justified. The
normal ratio of females to males with thyrotoxicosis is 4:1
(Williams 1962, p. 170), but in the reported cases of chronic
myopathy there were, in fact, more males than females (38:35) and
this suggests that the lesion is more common in men.
There was no significant difference between the two sexes,
so far as age was concerned, nor in the severity of weight loss
or the height of the basal metabolic rate, and the pattern of
muscles affected was much the same in both sexes. Prom this one
must assume that the longer duration of thyrotoxic symptoms and
myopathy in members of the female sex was due to their greater
ability to tolerate ill-fortune.
In 23% of the patients the muscle lesion was so prominent
that thyrotoxic symptoms were not a cause of oomplaint. In most
of the rest, however, the onset of muscle symptoms was concurrent
with those of hyperthyroidism. Most characteristically patients
had noticed difficulty in climbing stairs or trying to rise out
of a chair, some could not hold their arms up long enough to comb
their hair, seme had had great fatigue while walking along the
level, while a fewer number had no speoific muscle groups affected,
TABLE 1
















lAwber of patients 38 35
lean age 38 49.4 yrs* 33 45.8 yre.
Age range 20-63 11-70 yrs.
Mean duration of
snyppsthy
34 11*1 3the. 28 22*5 mths* 0.03^1^0.023
Mean duration of
thyrotoxicosis
28 11*3 «ths* 30 25*3 raths. 0.025 0.0123
lean weight loss 32 36.3 lbs* 21 33.2 lbs.
Presence of goitre 33 28 BG$, 27 26 96.3$
Presence of proptods 57 14 37 .art 27 13 48.15c
Presence of
ophthalmoplegia
37 3 3#lPf 27 1 3.73C Numbers ineuffioiei A
tor x 2 analysis.
'lean basal
iotabolio rate
32 + 43^ 28
Cluoose tolerance
diminished







0.03^ P ^ 0.25
* 3 (Hibrtio curves with oral .glucose ..olo ranee test*
#3 diabetic curves with oral glucose telnmsee test*
Table 1 continued.
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9 4 44.4$ 1 1 100#
Cases with fasoiou-
lation who did not
improve with
neostigmine.
9 5 55.5# 1 0 c#
9! One oa.se of fasoioulation not included because of old poliomyeolitis in affeoted limbs.
Bathurst (1895). Ayer, Means and Lerman (1934), Starling and Brain (1933)# Darice, Hunt and Brain (1938), ParsonB and Twort (1939),
MacKenzie (1940), del Castillo, de la Baize and Caul (1940), Morgan and Williams (1940), MoEachem and Boss (1942), Froment, Jeune
and Duverne (1942), Bartels and Pizer (1944), Thorn and Eder (1946), Proaent, G&llavardin and Derio (1946), Devio, Froment, Gvd.net
and Deric (1947), Sanderson and Adey (1949), Quinn and Worcester (1951 ), Zicrier (1951), Sanderson and Adey (1952), Millikan and
Haines (1953), Kite, McLintook and Graves (1954), Saorez, Lauseoker and Isch (1955), iloffenburg and Eales (1956), Collinge and
Lienhard (1957), Bostrom and Hed (1958), Had, Kirstein and Lundmark (1958), Melville (1959), Ellis and Carey (1961), Whitfield
and Hudson (1961) and Havard (1962).
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but complained of a generalised weakness. Severe paresis affect¬
ing all muscle groups was precipitated in one patient (Collings
and Lienhara 1957) by a glucose tolerance test and was relieved by
the administration of potassium chloride. In the 73 patients
movements least affected were those of the hand. Only two
patients spontaneously complained of weakness of the hands. Five
patients out of the total had indeed no complaints at all which
were related to the muscles.
Four of the men had had upper respiratory tract infeotions
before the onset of severe muscular weakness (Ayer et al. 1934,
MacKenzle 1940, Morgan and Williams 1940) and two patients had had
thirst and polyuria (McEaohern and Ross 1942, Zierler 1951). It
is interesting to note that Zierler's patient had a daily urinary
output of 4-5 litres and a serum potassium of 2.0 mEq/litre
suggesting that the hypokalaeiaia may have caused renal tubular
damage. Additional features preceding and accompanying musole
weakness were diarrhoea in 10.9$ of the patients (del Castillo
et al. 1940, Morgan and Williams 1940, MacKenzie 1940, Devic et al.
1947, Zierler 1951, Sacrez et al. 1955, Ellis and Carey 1961,
Whitfield and Hudson 1961), and vomiting in two cases. Two
patients described by Sanderson and Adey (1952) and by Millikan
and Haines (1953) had had cramps in their legs, while Hoffenburg
and Bales (1956) described a man with pain and stiffness in his
muscles and contractures, and muscular aohing was noted by
Whitfield and Hudson (1961).
There was proximal involvement of muscle in all the oases
described in the literature. 3n 44$ these were the only ones
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affected by the myopathy, in a further 40$ there was evidence of
distal involvement and in the remaining 16$ weakness of bulbar
musoles also occurred and there was no significant difference in
its incidence between the two sexes. Difficulty in speaking was
the most common symptom and consisted of dysphonia, hoarseness,
weakness of speech or an alteration in the quality of the voice.
Dysphagia was the second commonest sign of bulbar involvement and
It
the nasal regurgitation of fluids ooeurred in one patient.
41.7$ of the men were noted to have spontaneous muscle move¬
ments, compared with only 3.2$ of the women. Although the move¬
ments were variously described by the authors as fascioulation or
fibrillation, the latter are unlikely to have been seen, as was
explained earlier. Harman and Richardson (1954) considered that in
many of these patients the muscle twitching was in fact myokymia.
That the twitching was myogenic and not neurogenic was suggested
by McEachern and Ross (1942) who blocked the nerve to the affected
muscle with novocains and observed it3 continuance. Killikan and
Haines (1953) reported a normal innervation in one of their
patients who had muscle twitching. Nearly one-sixth of those in
whom neostigmine or edrophonium was tried derived some increase in
muscle strength and half of those who had fasciculations developed
greater strength following their administration. Both Kite et al.
(1954) and KeEaohen and Ross (1942) linked the fasciculations with
the improvement in power following neostigmine and postulated that
the fasoioulations were due to an undue sensitivity of the motor
end plate in a state of abnormal metabolism.
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Tendon reflexes were mostly normal. As nearly an equal
number were hyperactive as were diminished and a small number
were absent. Devic et al. (1947) described two cases in which
there were, in addition to muscle wasting and weakness, extensor
plantar responses and paraplegia. One died the day after opera¬
tion, the other recovered fully following thyroidectomy.
73.3$ of the men and 62.5$ of the women had evidence of
impaired tolerance to glucose. Two of these patients were known
diabetics and it is probable that most of the rest had "thyroid
diabetes", with a return to the normal state after remission of
their thyrotoxicosis. The high incidence of impaired glucose
tolerance is probably an indication of the severity of the thyro¬
toxicosis in these patients.
Rather more men than women had ophthalmoplegia (8.1$:3.7$)»
but the numbers are too small for statistical analysis. Part of
any difference oould perhaps be aocounted for "by the greater
incidence of nodular goitre (Hummer's Disease) in the women (4
cases), which charaoteristioally is not accompanied by ophthalmo¬
plegia, as compared with the men (1 ease).
INVEST 35ATIONS
Biochemistry. Apart from the constantly raised basal
metabolic rate, protein bound iodine or 1131 uptake, there have
been no constant biochemical features in the reported cases.
Five patient* had slightly raised serum calcium levels and two had
hypocalcaemia, but the vast majority were quite normal. A serum
potassium of 2.0 mEq/l was reported in one patient. Five patients
(2 with testicular atrophy) on whom urinary 17 ketostaroid estima¬
tions were carried out gave values at the lower limit of normal
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(Thorn and Eder 1946), apart from one man whose output was only
2.7 mg./24 hours. Sanderson and Adey (1952) reported a Robinson-
Power-Kepler test which was positive on two occasions and returned
to normal after treatment of the thyrotoxicosis and one of Thorn
and Eder's (1940) cases was found to have atrophy of the zona
glomerulosa of the adrenal cortex at postmortem. Sanderson and
Adey found evidence of impaired adrenal function in one of their
patients and suggested that the cause was subnormal production of
adrenocorticotropic hormone (1952) , whereas Daughaday and
Pair (1951) postulated a primary defect of adrenal responsiveness
in thyrotoxicosis.
Creatine and Creatinine Excretion. Creatine excretion in
normal adult men is usually almost absent and in adult women the
upper limit of normal is 50 mg./24 hours (Documents G-eigy 1962).
The normal range of creatinine excretion for normal adults is
1.071-3.219 g/24 hours with a mean of 2.145 g/24 hours (Doomenta
C-eigy 1962).
Table 1 shows that in the 73 cases of chronic thyrotoxic
myopathy reported the mean creatine excretion in men was 154.0
mg./24 hours, whereas it was 340.0 mg./24 hours in women.
Statistical analysis reveals this difference as being significant.
The figures for creatinine excretion were 1.009 g/24 hours for
males and 0.661 g/24 hours for females, the differences not being
statistically significant. Two of each sex had no creatinuria.
These were the cases of Zierler (1951) and Sanderson and Adey
(1952). Pipberger and his colleagues (1955) also reported absence
of creatinuria in 5 out of 13 thyrotoxic patients, and so it would
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appear that the pattern of excretion of creatine and creatinine in
hyperthyroidism is extremely variable. It seems likely that the
creatinuria and the low excretion of creatinine are partly due to
decreased muscle mass, and thus impaired storage of creatine which
is manufactured by the liver and kidneys, and partly to impaired
utilization of creatine by the muscles (Wilkins and Fleischmann
194.6). This is borne out clinically by the demonstration of
impaired creatine tolerance in thyrotoxic patients (Thorn and Eder
1946).
Electrocardiography. Apart from atrial fibrillation, the
electrocardiogram rarely showed any unusual features. However,
on three oocasions inversion of the T wave was noted and Morgan
and Williams (1940) described "slight myocardial damage" in one of
their patients.
Electromyography. Electromyographic investigation of
chronic thyrotoxic myopathy has been carried out in only a small
number of patients. The most characteristic finding has been a
reduction in duration and voltage of motor unit potentials
(Sanderson and Adey 1949» 1952, Sacrez et al. 1955)» a large number
of which were disintergrated in appearance (Hed et al. 1958,
Whitfield and Hudson 1962, Havard 1962) and there has been one
report of the presence of fibrillation (Hed et al. 1958).
Killikan and Haines (1953)» on the other hand, reported that there
was no abnormality in the electromyogram (E.M.&.) of any of their
four patients on whom it was carried out.
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A few other descriptions of the E.M.G. in thyrotoxicosis
have appeared in the last 15 years. Garcia Austt, Torrents and
Mussio-Foumier (1949), working in Montevideo, could find no
features which distinguished the E.M.G. of hyperthyroid patients
from normal, but they did note that the frequency was lower in
52$ of 17 thyrotoxics than in 50 normals at the onset of the con¬
traction of quadriceps against a load of 3 Kg. They found that
with successful treatment of the thyrotoxicosis the frequency
increased and the tracing went back towards normal or became com¬
pletely normal. They also said that there was some correlation
between the initial frequency of the E.M.G. and the height of the
B.M.R.. Gimlette (1959), on the other hand, found a high frequency
of the action potentials on volition, and discovered that a
majority of the thyrotoxic patients he tested had the "myopathic
pattern" described by Bauwens (1955). Evidence of myopathy, con¬
sisting of a shortening of the duration of action potentials, a
reduction in voltage and an increase in polyphasicity, was found
by Pipberger, Kalin and Wegmann (1955) in 12 out of 13 thyrotoxic
patients. Some electromyograms were carried out on several
muscles and an analysis of the results showed a clear preference
for the proximal musoles of the limbs as eompared with the distal.
One of the patients was found to have fibrillation potentials on
E.M.G.
These findings are typical of myopathy, no matter what the
oauae (Kugelberg 1947), 1949, Buohthal and Pinelli 1953, Pinelli
and Buchthal 1953, Eaton and Lambert 1957). The presence of
fibrillation in the patients of Pipberger et al. (1955) and Hed
et al«(l958) does not necessarily indicate denervation (Guy et al.
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1950, Eaton and Lambert 1957) and it has been shown by Adrian and
G-elfan (1933) that fibrillation can result from ionic differences
across the muscle fibre membrane. Buchthal and Rosenfalck (1963)
reported finding fibrillation potentials in half the muscles of
patients with muscular dystrophy, a condition in which the muscles
are known to contain a low concentration of potassium (Blahd,
Bauer, Libby and Rose 1953, Horvath, Berg, Cummings and Shy 1955)
but in whioh the serum oontent of that ion is quite normal.
Recently workers in Japan have discovered a significant reduction
in the intracellular content of potassium in musole obtained by
biopsy from thyrotoxic patients, with a concomitant rise in the
sodium concentration. (Satoyoshi, Murakami, Kowa, Kinoshita,
Noguchi, Hoshina, Niahiyama and Ito 1963).
Pathology. Askanazy wrote the first description of the
musole lesion of thyrotoxicosis in 1889. He noticed infiltration
of fat cells between muscle fibres, atrophy of muscle fibres with
a decrease in their diameter, proliferation and clumping of musole
nuclei, loss of striation and vacuolisation. Cardiac and smooth
musole showed no abnormality. Since 1898 a few further reports
have appeared. Many described much the same findings as Askanazy
(Dudgeon and Urquhart 1926, Morgan and Williams 1940, Bartels and
Pizer 194k, Quinn and Worcester 1951, Bostrom and Hed 1958, Havard
1962), but in addition aggregations of lymphooytes have been noted
in 5 articles (Dudgeon and Urquhart 1926, Lieohti 1938, Thorn and
Eder 1946, Hed et al. 1958, Whitfield and Hudson 1961). Eppinger
(1937) found capillary thiokening and pericapillary oedema.
Devic et al. (1947) described an alteration of the mitochrondria
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in the region of the motor and plates and demyelinisation and
vacuolisation of minor nerves was seen in one of Hed et al.'s
(1958) patients. C'ders and Woolf, using an intravital staining
technique, also found changes in the terminal nerve fibres, mainly
profuse distal sprouting, often with the formation of multiple end
plates on single muscle fibres,
e"fc (1958) noticed the presence in the muscle tissue
of iron loaded phagooytes. The presence of subsarcolemmal semi-
lumar accumulations of metachromatic substance observed by Asboe-
Hansen, Iversen and Wichmann (1953) in thyrotoxics, but most
markedly in those with progressive exophthalmos, has not yet bean
oonfirmed. The reason for this may be that the phenomenon was
only visible in muscles fixed in basic lead acetate which precipi¬
tated acid mucopolysaccharides, and was not found in tissue fixed
in aqueous media, suoh as formalin (iversen, Asboe-Hansen and
Carlsen 1953).
However, there have been several reports of biopsies carried
out on patients with thyrotoxicosis which have shown no abnormality
(Morgan and Williams 1940, Sanderson and Adey 1949» Millikan and
Haines 1953, Kite et al. 1954, Collings and Lienhard 1957> Adams
et al. 1962).
FTognosis. Some of the early oases died of respiratory
paralysis, but virtually all of the others made a full recovery
from their myopathy, largely due, no doubt, to the more effective
modern forms of treatment for hyperthyroidism. The rapidity of
the recovery of muscle power has sometimes been remarkable.
Peycelon (1946) described a patient who 3 days after thyroidectomy
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was able to lift both legs off the bed and hold them vertically,
a thing which had been quite impossible before the operation.
Ellis and Carey (19*>1) had a patient whose strength was returning
after two weeks* treatment with propylthiouracil and most other
authors noted a return to normality over the course of several
months, once treatment had been initiated.
KHDOCRIHE OPHTHAlMOPrr:£1A
This condition, which Is only indirectly related to the
thyroid gland, as it may occur in hypothyroidism, Gushing's syn¬
drome or in apparently euthyroid individuals, is characterised by
progressive exophthalmos, oedema of the lids and conjunctivae,
weakness of the extraocular muscles, usually those serving eleva¬
tion, convergence and lateral movement, and occasionally papil-
loedema and corneal ulceration. There seems to be little connec¬
tion between endoorine opthalmoplegia and the other muscle syn¬
dromes of hyperthyroidism, both on clinical and experimental grounds.
It has been pointed out that severe involvement of the eye occurs
more frequently following successful treatment of the thyrotoxi¬
cosis than during the course of the disease itself and it some¬
times arises in a patient suffering from hypothyroidism (Asboe-
Hansen et al. 1952, Brain 1959).
Physiologists hare shown that the administration of thyroid
extract or thyroxine to experimental animals did not, by and large,
produce exophthalmos, but that the latter could be initiated by the
administration of anterior pituitary extracts, especially when the
animals had had a previous thyroidectomy carried out (Brain 1959).
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Asboe-Hansen et al. (1952, 1953) measured the serum level of
thyrotropin and found it to be significantly raised in 9 out of 10
patients with progressive exophthalmos. More recently Kinderen,
Houtstralanz and Schwarz (1960) and Dobyns, Wright and Wilson
(1961) isolated a substance which they called the "exophthalmos
producing substance". It was believed to be an entity quite
separate from that of thyrotropin and there seemed to be a good
correlation between the presence or absence of exophthalmos and the
presence or absence of the substance in the serum of thyrotoxic
patients. The fact that the eye condition often regresses con¬
siderably following pituitary stalk section or hypophysectomy
(McCullagh, Clamen and Gardner 1957) provided confirmatory evidence
as to the pituitary origin of endocrine op hthalmoplegia.
Pathological changes have been described by several authors,
both in the extrinsic muscles of the eye and in the skeletal
muscles. Askanazy (1898) found similar changes in both sites.
Dudgeon and Urquhart (1926) observed lymphorrhages, sometimes peri¬
vascular, proliferation of interstitial cells and atrophy of muscle
fibres in the extrinsic eye muscles, where the changes were most
marked, in the deltoid and the biceps, and in the myocardium, where
they occurred less frequently. Dudgeon and Urquhart drew atten¬
tion to the similarity between these findings and those of myas¬
thenia gravis (Buzzard 1905). They also remarked that the thymus
was enlarged in three cub of their eight cases of exophthalmic
goitre. Similar ohanges were produced in the skeletal muscle of
thyroidectomised guinea-pigs by PaulBon (1939) who gave 30 daily
injections of antuitrin T, and the work was confirmed by Dobyns
(1946) who also noted, using speoial stains, that the muscle fibres
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were loaded with small droplets of fat. There seemed to he a
close correlation between the amount of fat found in the muscle
fibres and the degree of weakness produced in the guinea-pig and
it was also notable that the fatty change and weakness ooourred
as a relatively acute phenomenon, becoming less marked as the
injections of antritrin T ware continued. Dobyns had earlier
pointed out (1545) that thyrotropic hormone had toxic effects on
animals even before there was any effective thyroid response.
Reference has already been made to the presence in patients
with progressive exophthalmos of semi-lunar accumulations of muco¬
polysaccharide under the sarcolemmal covering of the skeletal
muscle fibres (Asboe-Hansen et al. 1952). Two papers by Ludwig,
Boas and Soffer (1950) and by Asboe-Hansen and Iversen (1951) des¬
cribed the finding of an accumulation of mucopolysaccharides, in
particular hyaluronic acid, in the orbital tissues. Later
Iversen and Asboe-Hansen (1952) explained the mechanism of pro¬
trusion of the eyeballs as being due to the water-binding action of
the mucopolysaccharides in the orbital tissues. 'Whether extensive
muscle paralysis can be produced purely secondarily to the retro-
orbital oedema with its resultant exophthalmos, venous occlusion
(Naffziger 1952, Dobyns 1950) and muscle stretching is not clear,
but it seems likely that there is also some primary muscle lesion
in ophthalmoplegia as it may occur without any clinically demon¬
strable exophthalmos (Logothetis 1961). In the 75 cases of thyro¬
toxic myopathy reported in the literature 5 patients with exoph¬
thalmos had abnormal skeletal muscle histology and in two it was
normal. (There was one patient with ophthalmoplegia in each group.)
Of the patients without exophthalmos 14 had an abnormal muscle
- 18
biopsy and 4 were reported on as being normal. There was no differ¬
ence in the histological picture between the patients with exoph¬
thalmos and those without.
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THYROTOXICOSIS AND MYASTHENIA GRAVIS
The combination of myasthenia gravis and thyrotoxicosis was
first described by Remak in 1899 (Logothetis 1961) and since then
it has been reported in more than 50 oases (Adams et al. 1962).
It has been estimated that 1% of thyrotoxics have myasthenia
gravis at some time in the course of their disease (Grob 1963) and
that the incidence of thyrotoxicosis preceding, accompanying or
following the clinical onset of myasthenia gravis is 5$ (Millikan
and Haines 1953). Millikan and Haines found that Q0% of the
patients with this combination were women and that the type of
myasthenia was the same as that found in patients without thyro¬
toxicosis. It responded to neostigmine, which, however, had no
effect on any associated endocrine ophthalmoplegia.
Some authors have attempted to find factors which are common
to both conditions. Cohen and King (1932) commented on the hyper¬
trophy of lymphatic tissue, the occasional presence of lymphocy¬
tosis and the finding of lymphorrhages in muscle tissue. In
addition the presenoe of atrophy or even necrosis of the muscle
fibres was noted by Russell (1953). An enlarged thymus is found
in half the thyrotoxic patients who come to postmortem examination
(Williams 1962, p. 157) and in recent autopsy studies approximately
one third of the patients with myasthenia gravis had thymomas and a
further quarter had hyperplasia of the thymus (Castleman and
Norrls 1949» Rowland, Aranow and Hoefer 1957)- Cohen and King
(1932) also compared the not infrequent occurrence of glycosuria
and lowered glucose tolerance in thyrotoxics with the definite
lowering of carbohydrate tolerance in myasthenia gravis.
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The relationship of myasthenia gravis and thyrotoxicosis des¬
cribed in the literature is oomplex. Millikan and Haines (1953)
reported that in their cases 48$ of the patients developed hyper¬
thyroidism before the myasthenia gravis. In 32$ the relationship
was the reverse and in 20$ the conditions occurred simultaneously.
Although KcEachean and Parnell (1948) described a 'see-saw'
relationship between the diseases, the myasthenia increasing as the
thyrotoxicosis receded and vice-versa, other reports have been
divided unevenly between the protagonists (Thomer 1939, Cohen 1946,
Maclean and Wilson 1954) and those who described the opposite turn
of events or no obvious intraction. (Thorn and Tierney 1941,
Kowallis et al. 1942, Flynn 1944, Green 1949, Millikan and Haines
1953, Osserman and Silver 1961.) Adams et al. (1962, p. 599) take
the view that, whatever the factors are whioh cause the occurrence
of the two diseases at the same time, the thyrotoxicosis does not
make the myasthenia gravis worse per se, but merely adds on the
weakness of hyperthyroidism to that of the former condition. Thus
the response to neostigmine cannot be expected to be total.
THYROTOXICOSIS AND PERIODIC PARALYSIS
More than 200 cases of concurrent thyrotoxicosis and periodic
paralysis recorded in the literature have recently been reviewed by
Engel (1961), who found that most cases were of a sporadic rather
than a familial nature and tended to occur at an older age (Grob
1963k, p. 167) than in the uncomplicated type of periodic paralysis.
3h rather more than 80$ of the cases the thyrotoxicosis antedated
or appeared at the sens time as the periodic paralysis.
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Serum potassium levels have been reported as being low in
some, but not all, patients with the combination of the two
diseases (Talbott 1941, Goldberg and Barnett 1961). Most cases
remit once the thyrotoxicosis is brought under control. To empha¬
size that there is a direct relationship between thyroid over¬
activity and the degree of paralysis a man (Hildebrand and Kepler
1941) with a family history of periodic paralysis, and who had
himself suffered minor and infrequent attacks, developed hyper¬
thyroidism and immediately the attacks began to get severe and more
frequent. Hildebrand and Kepler and also Ziegler (1949) infused
potassium intravenously into patients in an attack with known hypo¬
kalemia, but without producing any response.
MISCELLANEA
Generalised Myokymia in Thyrotoxicosis
This form of muscle twitohing has been reported only once in
association with thyrotoxicosis (Harman and Richardson 1954), though
the authors regard the cases reported by Morgan and Williams (1940)
and MoEaehean and Ross (1942) as exhibiting myokymia. Possibly
some of the other cases of thyrotoxic myopathy reported as having
fasciculations had in fact myokymia. The myokymia, which may occur
in normal people, especially under conditions of fatigue, is
observed, as coarse muscular twitchings, easily visible through the
skin. The spontaneous activity continues after spinal or high
nerve block, but is stopped by curare and is not increased by pros-
tigmine, thus placing the origin somewhere in the peripheral nerve.
Electromyographic studies show that nerve excitability is increased,
but that there is no evidence of a lower motor neurone lesion.
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Muscle Rigidity and Spasm with Thyrotoxicosis
Werk, Sholiton and Marnell (1961) presented the case of a
man who exhibited the "stiff man" syndrome - originally desoribed
by Moersch and Woltman (1956) - and thyrotoxicosis. This middle-
aged man complained of weakness, stiffness in his muscles and
difficulty with swallowing. Investigations confirmed hyper¬
thyroidism and treatment with radioactive iodine improved his
stiffness to some extent, but did not abolish it. There was a
large amount of psychological overlay in this patient, and it is
hard to know whether the stiffness represented a true association
with thyrotoxicosis, though in two cases of thyrotoxic myopathy
desoribed by Sanderson and Adey (1952) and by Millikan and Haines
(1953) muscle cramps were a prominent feature and a patient with
pain and stiffness in his muscles was reported by Hoffenburg and
Ealea (1956)
Myotonic Dystrophy
Two cases of thyrotoxicosis occurring in patients with
myotonic dystrophy have been noted (herkman 1935» Leach 1962).
In both oases there was a marked improvement in strength following
treatment of the hyperthyroidism; in one case coincident bulbar
symtoms also disappeared and in the other the degree of myotonia
was lessened. It is not suggested that there is any relationship
between the two conditions other than that of chance, but it seems
likely that both were cases of myotonic dystrophy with superadded
thyrotoxic myopathy.
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AIM OP THE THESIS
This review of the literature has "brought out some similari¬
ties which occur between the various skeletal muscle conditions
associated with overactivity of the thyroid gland. These simi¬
larities are summarised in Table 2 and it can be seen that the
condition of acute thyrotoxic myopathy ("encaphaloiayopathy")
resembles very closely that of chronic thyrotoxic myopathy, the
only difference being the more frequent sudden onset of bulbar
symptoms in the former. The muscle histology is almost identical.
The resemblance between the aoute and chronic forms of
myopathy and both myasthenia gravis and periodic paralysis is not
quite so striking, but it will be noted that the degeneration of
muscle fibres and vacuolisation within the fibre have been des¬
cribed in all four conditions. Also, cases have been reported
in each disease in which there was some upset of potassium meta¬
bolism and attention is drawn to the enlargement of the thymus in
both thyrotoxicosis and myasthenia gravis.
Experience in the Metabolic Clinic, Royal Victoria Hospital,
Belfast had suggested that muscle involvement was common in
thyrotoxicosis and it wan decided, therefore, to carry out a
detailed investigation of a series of conseoutive, unselected
patients presenting at the Metabolic Clinic with proven hyper¬
thyroidism in an attempt to discover more about the nature of the
muscle lesion.
It was thought that the most likely explanation for the
occurrence of the various muscular disorders was a constant
derangement of muscle metabolism in thyrotoxic patients. This
TABLE2











infection may be an aetio-
logieal agent (Simpson 1960)





Bulbar involvement usually Often bulbar involvement Usually bulbar paresis Rarely bulbar paresis
Upper motor neurone lesions
reported
Upper motor neurone lesion
on one occasion
ISypikalaemia reported Uypokalaesda reported
one case precipitated by













E.M.G. Myopathy B.M.G. Myopathy E.M.G. Myopathy E.M.G. - Myopathy during
an attack. (Shy, Wanko,
Rowley and Engel 1961).
Muscle pathology Muscle pathology Muscle uathology Muscle pathology





















Thymic enlargement Thymic enlargc.-ient Thymic enlargement
- 2k -
would produce weakness, followed later by secondary atrophy of the
muscle fibres and would unmask those people who also had latent
myasthenia gravis or periodic paralysis.
The main oriterion for the presence of a myopathy in the
patientB studied was the eleotromyogram. Muscle biopsies were
made in order to assess any histological abnormalities and to try




Patients. Fifty-four consecutive patients presenting at
the Metabolic Clinic, Royal Victoria Hospital, Belfast, on whom a
diagnosis of thyrotoxicosis was proven, were examined and investi¬
gated by the author for involvement of their musoles. The investi¬
gations carried out were electromyography, muscle biopsy, urinary
creatine and creatinine excretion, serum calcium and potassium, 2-
hour post-prandial bicod glucose and electrocardiography. When¬
ever possible the diagnosis of thyrotoxicosis was substantiated by
means of 1131 uptake and excretion studies done over 48 hours, but
occasionally 1132 neck uptakes were performed on outpatients living
at a distance, and at times estimations of the basal metabolic rate
only were made on a few patients who had reoently ingested iodine
in one form or another.
If the severity of the thyrotoxicosis warranted it, the
patient was admitted to hospital: otherwise the investigations
were carried out as an outpatient.
Because of the extreme nervous tension and anxiety in some
patients it warn not always possible to do all the investigations
on some individuals. However electromyographic studies were satis¬
factorily completed in all.
Clinioal Examination. A detailed history was taken in order
to establish, as accurately as possible, the duration of thyrotoxic
symptoms and their relationship to the onset of any muscular com¬
plaints. Patients were questioned closely about their ability to
perform movements with all major muscle groups and were asked about
difficulty in carrying out familiar everyday aotion3 suoh as combing
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the hair, hanging up washing, climbing stairs etc.
As well as a full clinical examination to establish the signs
of thyrotoxicosis and any associated pathology, particular attention
was paid to all muscle groups in the body. The rausoles were
examined for evidence of atrophy which was graded as none (o), slight
(+), moderate (++) or marked (+++).
A commonly used grading of muscular power is that of the
Medical Research Council (1949), but this was found unsatisfactory
as the severity of the weakness in the patients being studied was
confirmed to M.R.C. grade 4. A similar classification to that for
atrophy was therefore used, vis. no loss of power (o), some weakness
against resistance by the examiner's hand (+), moderate weakness
(++) and marked weakness (+++). Since clinical experience in the
earlier part of the survey had suggested that the iliopsoas was
more often affected than the quadriceps group, Lahey's (1926) test
was modified so that the patient lay down in bed and, holding the
knee straight raised the leg to an angle of 45° and maintained it
in this position until able to do so no longer. The test was per¬
formed at the initial examination before and after the intravenous
injection of 10 mg. of edrophonium chloride (Tensilon),
Visible spontaneous muscle activity was searched for with the
patient in a state of complete relaxation.
The thyroid gland was oarefully palpated in order to determine
whether the goitre was diffuse or nodular.
Evidence of ophthalmoplegia was looked for and the degree of
proptosis measured with a Keeler exophthalmometer at the initial
and subsequent visits.
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Electromyography* Electromyography was done at the time of
the first examination and was repeated four months after the
patient had been rendered euthyroid. One proximal muscle was
sampled in each patient and the two muscles ohosen were deltoid
and rectus femoris. The triceps was tested on one patient.
Over a third of the patients also had. an electromyogram done on
abduotor digiti quinti.
Controls were obtained for each of the muscles tested. The
controls consisted of people of all age groups who were either
completely healthy or had no neuromuscular pathology, primary or
secondary (e.g. diabetes mellitus, Addison's Disease, malignant
neoplasms etc.).
Care was taken while doing follow up electromyograms on
treated patients to ensure that the area of muscle near the biopsy
site was not sampled.
The examinations were done with a D.I.S.A. three channel
electromyograph. The amplifiers had a frequency range of 2 to
10,000 c.p.s. (Guld 1951) defined by 3 db. discrimination, the
input impedance was 100 megohms shunted with 60 pF (single ended)
and the noise level was leas than 1.5uV r.m.s. with a shorted
input. Concentric needles, consisting of a platinum lead embedded
in Araldite within a stainless steel cannula, were used. The
area of the platinum surface was 0.07 sq. mm. The tip of the
needle was cut obliquely at an angle of 15°. An O.65 mm. diameter,
42 mm. long needle was used for proximal muscles and an 0.45 mm,
diameter, 30 mm. long needle for distal muscles. The same needles
were used on both the thyrotoxic patients and the controls.
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The electrode impedance was kept as low as possible by check¬
ing it every two months. If the noise level was greater than 15 pV
peak to peak the electrode was plaoed In 0.9$ NaCl solution and 6 volts
D.C. was applied for two seconds between the platinum electrode
and the cannula.
The eleotromyogr&m was checked regularly for the acouraoy on
the cathode ray tubes of the time base and amplitude. This was
done with the built in square-wave calibrator. ?rinor adjustments
were rarely necessary.
The electroayograms were done by using three needle elec¬
trodes simultaneously. Rach needle was inserted at random into
the selected muscle and recordings were taken at minimal effort.
Each needle was then advanced 1 cm. in the proximal muscles and at
least 0.5 cm. in the abductor digiti quinti and the procedure was
repeated. After the needles had been pushed in for a further 1
cm, and recordings had been taken, they were withdrawn and inserted
twice more in other parts of the muscle, with three depths at each
insertion. Thus, in all, 27 different parts of each muscle were
sampled (Buehthal and Rosenfalck 1955). Intramuscular tempera¬
tures were not taken, but the patients were examined in a room kept
at a constant temperature of 22°c, since it has been shown that
cooling inoreases the aotion potential duration and also the per¬
centage of polyphasle forms (Buehthal and Pinelli 1951).
Recordings were taken at sweep speeds corresponding to 1 m.
sec. per mm. with an amplification such that 1 mm. on the cathode
ray screen was equivalent to 10 pV, The paper speed was 5 am.
per sec. If the whole potential could not be seen, the amplifi¬
cation was increased until it could be. The action potential
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duration was only measured at an amplification of 10 uV/mm. in
order not to miss minor deflections from the ba3e line.
At the end of the sampling procedure a recording was taken
of the pattern of activity at full effort.
The films were developed and analysed for action potential
duration and amplitude and the degree of polyphasicity. Each
action potential was identified three times and the duration was
measured from the first to the last deflection from the base line.
The amplitude was measured as the peak to peak deflection
(Buchthal, Guld and Resenfalck 1934). The mean of the three
readings was regarded as the characteristic for that potential.
Any potential with five or more deflections across the base line
was categorised as a polyphasic potential, but it also had to be
identified three time3 before it was accepted as such. All the
potentials in the record which could be identified three times
were measured and sufficient length of record was taken to ensure
that this included at least 20 different potentials, other than
polyphasics. The mean duration and amplitude for the whole
muscle and the percentage of polyphasic potentials was then cal¬
culated. Polyphasic potentials were not included in the calcula¬
tions to determine mean action potential duration and amplitude
(Buohthal 1957).
The pattern at maximum effort was classified as a normal
interference pattern, mixed pattern or single motor unit poten¬
tials. The peak to peak voltage was measured whenever it was
felt that the record represented the maximum contraction of which
the patient was capable.
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Motor nerve conduction velocities. Studies were carried
out on the ulnar nerve of 12 patients. The 3 recording elec¬
trodes were placed in the abductor digiti quinti and the nerve
was stimulated at the wrist and also above the elbow with the
B.I.S.A. Kultistia. The stimulus given was twice the threshold
stimulus for that patient. The latency from the wrist to the
muscle and the conduction velocity between the elbow and the wrist
was calculated for each needle and an average of the three was
then taken. Control measurements were done on subjects of all
ages who were either normal or had no neuromuscular disease.
Iviuaole biopsy. Biopsy wa3 carried out on the proximal
muscle which had been examined electromyographioally. The biopsy
was always dona on a part of the muscle which had not had elec¬
trodes inserted into it.
Control biopsies were done, usually on patients undergoing
operation for varicose veins or inguinal hernia. Unfortunately
it was rarely possible to obtain tissue from the rectus femoris
or deltoid muscles.
The biopsy was performed according to the method suggested
by Buohthal, Guld and Rosenfalok (1955). In the patients
xylooaine without adrenaline was used for skin anaesthesia; in
the controls the operation was always under general anaesthesia.
A piece of muscle 1.5 cm. x 0.5 cm. x 0.5 cm. was removed. The
muscle sample was not touched with instruments or swabs, ligatures
being tied round each end and the muscle tissue being divided
distal to the ligatures. The biopsy specimen was stretched out
on a piece of ocrk, pinned at each comer with a wooden sliver
and placed in U-% neutral formaldehyde at 37°c, These precautions
were taken in order to minimise damage done to muscle tissue and
also to prevent the fibres from going into a state of severe con¬
traction. The fixing medium was maintained at 37°o. for 24 hours,
then allowed to cool to room temperature.
After fixation the specimen was embedded in paraffin and
sections 5 d thick were out both perpendicular to and in the plane
of the muscle fibres. They were stained with haematoxylin and
eosin and van Gieson. The sections were examined for histological
abnormalities and, on suitable specimens, the muscle fibre popula¬
tion and mean diameter were measured. Only sections in which
there was a true cross-section of the muscle fibres, that is one
in which the fibres appeared round or polyhedral, were used for
these estimations. The fibre population was measured by counting
all the fibres in 35 squares of a grid incorporated in the micro¬
scope eyepiece. The size of this area on calibration was 1.05 sq.
mm, and so the density could be calculated. The fibre diameter
was measured with a scale, each division of which represented 25 d,
This was also incorporated in the microscope eyepiece. A hundred
fibres were counted except in a few instances where there were
*
.
insufficient fibres which were truly oross-sectional.
Urinary creatine and creatinine excretion. Twenty-four
hour samples of urine were collected both before treatment and four
months after the patient had become euthyroid. The creatine and
creatinine estimations were done by the Auto-analyzer standard
method (1962).
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Sezmm calcium. Serum calcium was measured with the flame
photometer (Fawcett and Y/ynn 1961).
Serum potassium. Estimations of serum potassium were made
using the Auto-analyser standard method (1961).
Blood glucose. The Auto-analyzer standard method (i960)
was used for blood gluoose estimations. The blood samples for




The Patients. Fifty-four oonseoutive thyrotoxic patients
were examined, investigated and followed-up during the course of
the survey. Tables 3 and 7 summarise the main features, details
of which can be found in Appendix Tables 1 and 2.
Forty women and 14 men were seen, giving a female to male
sex ratio of 2.9:1. The mean age of the patients was 47.9 years,
and there was no significant difference between the mean ages of
the male and female patients.
Fifty per cent of the patients gave a history of some
muscle weakness. The most common symptom was that of difficulty
in going up stairs (15 patients). A slightly smaller number of
patients (13) complained of weakness of the arms, in particular
the proximal muscles. The women often complained of being unable
to brush or comb their hair without resting, and of excessive
fatigue when putting up curtains or taking things from high
shelves. The men, especially the manual workers, had noticed a
decline in their ability to lift or push heavy objects and often
required help in performing tasks which previously they had been
quite oapable of managing alone. There were no complaints of
weakness affecting the bulbar muscles. There was no statistical
difference between the ages of patients with muscular weakness and
those without (Table 3).
79.6$ of the patients had noticed the onset of typical
thyrotoxic symptoms as the first feature of their illness: in
3.7$# weakness had been the presenting feature, Jh 16,7$ of the
patients there was a simultaneous onset of the usual thyrotoxic
TABLE 3
The main characteristics of the patients, with particular
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- 34 -
symptoms with those of muscle weakness. In all three groups
there were no differences between males and females.
Of the patients who had had some complaints of weakness
there was, in fact, no difference between the duration of their
thyrotoxic symptoms and that of their weakness (0.2> P»0.1).
The same mean weight loss of 17.5 lb. occurred in both men
and women and, as Table 4 shows, there was no correlation between
the age of the patient and the amount of weight lost.
Clinical Examination
63$ of the patients were found to have weakness and/or
wasting of proximal muscles alone, 18.5$ had involvement of both
proximal and distal muscles, and the remaining 18.5$ had a com¬
pletely normal skeletal musculature. Two patients had slight
slight-atrophy without any weakness and 12 had weakness without
any sign of wasting. In the other patients with muscle involve¬
ment, the wasting and weakness was usually of equal degree.
There was no difference in the mean age of those patients
with muscle involvement compared with those without. Table 5
shows the number of patients in whom each muscle was involved,
and it can be seen that the muscles of the shoulder girdle were
more often affected than those of the pelvic girdle and, in par¬
ticular, that extensors were twioe as commonly affected as
flexors. Pigs. 1a and 2a show two patients with marked wasting
of the shoulder and pelvic girdles respectively, and these can
be compared with photographs taken four months after becoming
euthyroid (Figs. 1b and 2b).
Table 4
Relationship between the age of
the thyrotoxic patients and the









at P * 0.5
(b)
Fig. 1. Case No. 22. Male aged 38.
(a) Shoving marked wasting of shoulder girdle
muscles while thyrotoxic.
(b) Four months after becoming euthyroid.
(b)
Fig. 2. Case No. 15. Male aged 64.
(a) Showing wasting of gluteal muscles while
thyrotoxic.
(b) Four months after becoming euthyroid.
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The tendon reflexes were normal in 29 patients (53.7$)*
brisk in 23 (42.6$) and reduced in 2 (3.7$). No sensory abnor¬
malities were found.
Effect of Edrophonium. The length of time for which 19
o
patients could maintain each leg at an angle of 45 to the hori¬
zontal was measured and the average of the two taken. The
patients were then given 10 mg. of edrophonium chloride (Tensilon)
intravenously and the test was repeated. Table 6 shows that the
edrophonium produced no significant increase in strength
(Appendix Table 3).
Ophthalmoplegia. One of the 14 men (7.1$) and three of
the 14 women (7.5$) had ophthalmoplegia. Each of the three women
had other diseases in addition to her thyrotoxicosis. One had
diabetes meHitus, another diabetes mellitus and pernicious
anaemia and the third had concurrent myasthenia gravis, affecting
only her eyes. As Pig. 3 shows, her ptosis responded well to
the injection of edrophonium, but her ophthalmoplegia persisted.
Investigations
(Table 7 and Appendix Table 2)
The presence of thyrotoxicosis was proved in all the patients
by means of thyroid 1131 or 1132 uptakes, and occasionally by
estimations of the ba3al metabolic rate or serum protein bound
iodine alone (Appendix Table 2).
Electrocardiography. Electrocardiograms were done in 50
of the 54 patients, and the results are summarised in Table 8.
18$ of the patients had an abnormal rhythm, usually atrial
Table6
19Thyrotoxicpatients
Timelegscould,bemaintainedinelev tion beforeandfterthadministrationof edrophonium(Tensil ).















Pig. 3» Case No. 28. Female aged 35 with concurrent thyro¬
toxicosis and myasthenia gravis. (a) Showing ptosis. (b)
Patient attempting to look to the left. (o) and (d) following
the intravenous injection of edrophonium. (e) One month later,
showing ophthalmoplegia unresponsive to edrophonium.
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Analysis of the electrocardiograms of
50 thyrotoxic patients.
E.C.G-. normal 2 4$
Sinus tachycardia 36 72$
Atrial fibrillation 7 14$
Atrial ectopic beats 1 2$
Atrial flutter 1 2$
Left ventricular hypertrophy 19 38$
Qy *VL 3 6$
Plat T wave 3 6$
ST depression 2 4$
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fibrillation, and all of these except one had significant
associated skeletal muscle weakness. 6% had Q waves in leads 3
and aVL, had flattened T waves in various leads and b-% had ST
segment depression. The vast majority had sinus tachycardia
(72^), and just over half of these patients showed evidence on
the electrocardiogram of left ventricular hypertrophy.
Blood Glucose. Estimations of the blood glucose two
hours after a meal containing at least 100 grammes of carbohy¬
drate were done on 45 patients. The mean value was 111.2 mg.^S,
and 42.2?5 of the patients had a value which was abnormally
raised, that is above 110 rag.Jc, indicating diminished glucose
tolerance (Williams 1962, p. 616).
Serum Calcium. Estimations were performed on 49 patients.
The mean value was 10.0 mg.$ and all the patients lay within the
normal range of 9.5 - 10.5 ng.fe, except for three patients whose
values were between 9.0 and 9.5 mg.$ and six others who had mild
hypercalcaemia, the highest level being 11.9 mg.$.
Serum Potassium. Estimations on 48 patients gave a mean
value of 4.3 mEq./l. Three had values whioh were just below
the lower limit of normal of 3.5 mEq./l, and four others had
values above 4.8 mEq./l, which is the upper limit of normal.
Urinary Creatine and Creatinine Excretion. Twenty-four
hour excretion of creatine and creatinine was measured in 44
patients. The mean excretion of creatine was 264.4 mg./24
hours, and there was no significant difference between the values
for men and those for women. The normal range for creatine
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U3ing the Auto-analyzer standard method (1962) is 0 - 200 mg./24
hours. Six out of the 12 men and 17 out of the 32 women had
figures within the normal range. The lowest figure for a thyro¬
toxic patient was an excretion of 8 mg. of creatine in 24 hours.
The mean figure for creatinine excretion was 936.8 mg./24
hours, and again there was no significant difference between
male and female patients in this respect. Most of the values
for the men lay below, or at, the lower limit of the normal range
for their sex, which is 1.0 - 2.4 grams, done by the Auto-
analyzer standard method (1962). The figures for the women
patients were similarly related to the normal range for females
(0,7 - 1.3 grams).
Electromyography
Electromyograms were carried out on all 54 patients. A
proximal muscle was tested in each patient - in 29 patients the
deltoid muscle was chosen, in 24 the rectus femoris and in one
oase the triceps. In 21 patients abductor digiti quinti was
also sampled.
Deltoid
(Appendix Tables 4 and 5)
Action Potential Duration. Table 9 and Fig. 4 show that
in the control subjects there was a highly significant correlation
between age and the mean aotion potential duration, the duration
becoming greater with advancing years. All of the 29 thyrotoxic
patients tested had mean action potential durations which were
significantly different from the predicted for their age (Table 10).
Fig. 4* Deltoid. Graph shoving the relationship bstveen age
and mean action potential duration in oontrol subjects and in
thyrotoxic patients.
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Thyrotoxic patients. Deltoid. Table ahowiag the


















7-i«*»51 nificanee of deviation
t P
1 42 8*7 12.0 3.3 6.976 P< 0.001
4 47 8.8 12.2 3.4 7.203 P< 0.001
10 38 7.4 11.8 4*4 5.301 P< 0.001
11 50 7.9 12.4 4.5 5.533 P< 0.001
12 48 7.6 12.3 4.7 $.978 P< 0.001
13 32 7.3 21*5 4.2 £.860 P< 0.001
14 26 8*3 11.2 2.9 6.066 P< 0.001
15 64 9.6 13.1 3.5 7.231 P< 0.001
17 69 7.5 13.3 5*8 11.812 P < 0.001
18 64 8.6 13.1 4.5 $.297 P< 0.001
19 66 7.5 13.2 5.7 11.704 P< 0.001
20 39 7.1 11.9 4.8 1C.191 P< 0.001
22 38 8*4 11*8 3.4 7.218 P< 0.001
24 56 7.8 12.7 4.9 1C.294 P< 0.001
25 55 9.5 12.6 3*1 6.500 P< 0.001





1C.593 P < 0.G01
29 53 7.9 12.5 4*6 9.704 P < 0.001
30 49 9.1 12.3 3*2 - 6.956 0.001
31 50 10.9 12*4 1.5 3.177 0.005>PX).001
32 52 10.5 12.5 2*0 4.219 P< 0.001
35 15 7.4 10.7 3.3 6.72Q P< 0.001
37 36 10.1 11*7 1.6 3.397 0.005>P>0.001
38 58 5.7
.
12.8 7.1 14.853 ? <0.001
45 55 11*6 12.6 1.0 2.100 G.C5>P>0.01
48 27 7.6 11*5 3*7 7.756 P < 0.001
49 42 8.2 12.0 3.8 8.067 P <0.001
50 69 8.9 13.3 4.4 8.961 0.001
53 64 9.1 13.1 4.0 6.264 P <0.001
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Action Potential Amplitude. There was no association
between age and the mean amplitude of the action potentials
(Table 11), and, although the average amplitude in the thyrotoxic
patients was lower at 95.8 uV than that of the control subjects
at 112.4 dV, there was no statistical significance in this
difference (Table 12).
Polyphaslo Potentials. The mean percentage of polyphasic
potentials measured in the deltoid muscle of control subjects
was 9.6$» and the percentage found in the patients was signifi¬
cantly higher at 19.8# (Table 13 and Pig. 5).
Spontaneous Activity. Fibrillation potentials were
observed only once in the deltoid muscle of a thyrotoxic patient.
Fasoiculation was observed on one occasion in a different patient.
Electromyogram on Maximal Volition (Appendix Table 7).
All the deltoid EMG-'s showed a normal interference pattern on
maximal effort. The mean peak to peak voltage was not signifi¬
cantly lower than that of controls (Table 14).
Rectus Femoris
(Appendix Tables 4 and 6)
Action Potential Duration. As with the deltoid muscle,
the correlation in the control EMG-'s between age and action
potential duration wa3 highly significant (Table 15 and Pig. 6).
However, although 20 (83.3$) of the thyrotoxic patients had mean
action potential durations which were significantly different
from the predicted for their age, four patients had values which
were within the normal range (Table 16).
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Table12
Deltoidelectromyograms















Hg* 5* Deltoid and Rectus femoris. Showing the differences
in the percentage of polyphasio potentials between thyrotoxic
patients and control subjects.
Table13
Deltoidlectrooyograms


























Pig. 6. Rectus femoris. Graph showing the relationship
between age and mean action potential duration in control
subjects and in thyrotoxic patients.
TABLE 15
Control Subjects, Rectus femoris. Correlation between age









2 56 13.3 x = 45.6 yra.
3 61 14.2 y = 13.1 m sec.
4 72 13.5
5 60 14.1 by.x. * 0.041
6 43 12.8 S.D. a 0.92 m sec.
7 63 14*3 r * 0.61
8 52 13.9 0.01>P> 0.001
9 73 14.1 Highly sig¬
10 43 14.5 nificant at








Thyrotoxic patients. Rectus femoris. Table
showing the deviation of the observed mean action


















Statistical significance of deviation
t P
2 48 8.1 13.2 5.1 4—411 P <0.001
5 60 8.5 13.7 5.2 5.469 P < 0.001
6 22 8.7 12.2 3.5 3.390 0.005>p>0.001
7 57 10.1 13.6 3.5 3.611 0.005>p>0.001
8 37 11.9 12.8 0.9 0.901 0.4>P>0.3
9 53 10.7 13.4 2.7 2.836 0.02>P>0.01
16 50 9.8 13.3 3.5 3.670 0.005>P>0.001
21 70 8.8 14.1 5.3 5.264 P< 0.001
23 53 10.5 13.4 2,9 3.049 o.or>p>o.oo§
27 55 10.9 13.5 2.6 2.690 0.02>P>0.01
33 28 6.9 12.4 5.5 5.629 P< 0.001
34 31 9.9 12.5 2.6 2.709 0.02>P>0.01
36 48 9.9 13.2 3.3 3.484 0.005>p>j.001
39 25 10.2 12.3 2.1 2.125 0.1>P>0.05
¥> 65 10.8 13.9 3.1 3.133 0.01>P>0.005
41 48 8.3 13.2 4-9 5.174 P<0.001
42 53 8.1 13.4 5.3 5.578 P <0.001
43 6o 7.9 13.7 5.8 5.980 P <0.001
44 62 8.9 13.8 4.9 5.000 P< 0.001
46 67 10.6 14.0 3.4 3.390 0.005>P>0.001
47 40 11.2 12.9 1.7 1.770 0.1>p>0.05
51 39 10.8 12.8 2.0 2.147 0.05>P>0.025
52 a 10.9 12.9 2.0 2.128 0.1>P>0.05














Pig. 7. Part of EM& done on the rectus femoria of case 7.
(a) Amplification at 10 HV/ma (b) Amplification at 20 n V/ma
(o) Interference pattern. Amplification at 100 ^ V/mm.
Pig. 8. Part of EMG- done on rectus femoris of control subject
(No. 3 ) (a) Amplification at 10uV/mm (b) Amplification at
20 uV/mm (c) Interference pattern. Amplification at 100uV/mm
H v. '
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Action Potential .Amplitude. There was no correlation
between age and action potential amplitude amongst the controls
(Table 17), and a comparison of their figures with those of the
thyrotoxics (158.9 m-V and 15*1.5 uV respectively) showed that there
was no real difference (Table 18).
iOlyphasio Potentials. The controls had a mean percentage
polyphasicity of 8.2 and that of the thyrotoxic patients was sig¬
nificantly higher than this at 14.(Table 19 and Pig. 5).
Spontaneous Activity. No evidence of fibrillation or
fascioulation was found in the EMG-'s done on rectus femoris.
Electromyogram on l/jaximal Volition. In interference
pattern was seen in all the patients except three who had a mixed
pattern on maximal effort. There was a highly significant
reduction in voltage (mean 2.5 mV") compared with controls (mean
4.5 mV) (Table 20).
Triceps
This muscle was sampled in one patient and in two controls,
details of whose electromyograms are given in Table 21.
Neither the patient nor the controls had any evidence of
spontaneous activity, and all three subjects showed a normal
interference pattern on maximal effort.
No statistical analysis has been done on the EMG-'s of
triceps because of the small numbers, but it is probably that
there was a reduction in the patient's action potential duration
and an inorease in the percentage of polyphasic potentials.
Table 17
Rectus fernoris eleotroayograma. Control subjects.
Relationship between age and mean aotion potential











at P = 0.05
Table18
Rectusfemorilectr myograms





























































































Action Potential Duration. Unlike the two proximal muscles
already described, there was no correlation in the EMG-'s done on
abductor digiti quinti between age and mean action potential
duration (Table 22). Of the 21 thyrotoxic patients tested, only
9 (42.9$) bad a mean duration which ley outside the normal range
of 9.3 i 2.1 m. sec. (Table 23 and Fig. 9). All the 9 patients
had abnormal proximal electromyograms.
Action Potential Amplitude. The mean amplitude for con¬
trols was 154.9 |iV" and that for the thyrotoxic patients 129.9 |jlV,
but statistical analysis did not reveal any significant difference
between these figures at the P = 0.05 level (Table 24).
Polyphasic Potentials. The patients had a higher degree
of polyphasicity (13.6$) than the controls (9.9$), and this dif¬
ference was significant (Table 25 and Fig. 10).
Spontaneous Activity. Fasciculation was seen in 3
patients, one of whom had it in 7 of the 27 positions sampled.
Fibrillation potentials were observed in 3 cases.
Correlations
Sex. Taking the deviation of the observed mean action
potential duration from the predicted for each patient as an indi¬
cation of the degree of abnormality of the electromyogram, a com¬
parison of the male and female patients (Table 26) shows that
there was no significant difference between the two groups.
TABLE 22
Control Subjects# Abductor digiti quinti. Correlation












5 22 9.0 x = 43.3 yr.
6 71 9.7 y = 9.3 m sec.
7 68 11.3
8 57 9.4 b = 0.014
yx
9 55 9.5
10 42 8.7 r = 0.249
11 45 8.4
12 26 10.7 P >0.1








lO 20 SO 40 SO
AGE (YEARS)
60 70 SO
Fig. 9* Abductor digit! quinti. Graph shoving the swan action
potential duration in thyrotoxic patients and in control subjects
TABDS 23
Thyrotoxic patients* Abductor digiti quinti. Table
showing the deviation of the mean action potential














18 64 7.0 -2.3 +
23 53 11.0 +1.7 0
24 56 8.6 -0.7 0
25 55 6.0 -3.3 +
26 52 6.7 —2.6 +
29 53 5.9 -3.4 +
30 49 8.5 —0.8 0
31 50 10.5 +1.2 0
32 52 9.3 0 0
34 31 7.2 -2.1 +
36 48 7.4 -1.9 0
37 36 6.8 -2.5 +
40 65 7.4 -1.9 0
4i 48 6.3 -3.0 +
42 53 7.3 -2.0 0
44 62 8.9 —0.4 0
45 55 8.8 -0.5 0
46 67 7.3 -2.0 0
46 27 7.2 -2.1 +
49 42 7.9 -1.5 0
53 64 5.6 -3.7 +
Table24
Abductordigltiq intielectromygrams














































Age. There was no oorrslation between age and the deviation
of the mean action potential duration froa the predicted (Table 27)
In the *niC''a done on the deltoid muscle, all groups being equally
affected (?ig, 4), but there was an association in the recordings
taken from the rectus femoris (Table 28), It can be seen from
fig. 6 that the patients under the age of 45 were less severely
affected than those in the older age groups, and statistical analy¬
sis (Table 28 and Tig. 11) ahuw that thia correlation in rectus
femorls is significant.
Duration of Thyrotoxicosis. Tables 29 and 50 reveal no
association between the tine for which the patient had thyrotoxic
symptoms and the severity of the electromyographic findings,
( Appendix Tables 12 and 13)
severity of Thyrotoxicosis. Using the level of the serum
protein bound iodine in 51 patients as an indication of the
severity of the thyrotoxicosis, a comparison of this with each
patient's deviation of observed mean action potential from the pre¬
dicted revealed that there was no correlation at all (Table 51 «nd
Appendix Table 14).
'••elriht lose. An analysis of the IM&'s done on the deltoid
end rectus fenoris muscles revealed no positive relationship
between the severity of the elect rosyographic action potential
deviation and the amount of weight lost by the patient (Tables 32
and 53 and Appendix Tables 12 and 13).
Clinical T e&jqtefis of the fusole MB81&S&1 There was a sig¬
nificant difference between the seen action potential deviation in
Table 27
Deltoid. Thyrotoxic Patients.
Relationship between age and the deviation of the
observed mean action potential duration











at P s 0.05
Fig. 11. Rectus femoria. Graph showing a correlation in thyro¬
toxic patients between age ana the deriation fron the expected
mean action potential duration.
Table 28
Rectus femoriB. Thyrotoxic patients
Relationship between age and the deviation of the
observed mean action potential duration









0.05 > P > 0.01
Significant
at P = 0.05
Table 29
Deltoid. Thyrotoxic patient#.
Relationship between the duration of the thyrotoxicosis and
the deviation of the observed mean action potential











at P * 0.05
Table 30
Rectus femoris. Thyrotoxic patients.
Relationship between duration of thyrotoxicosis and the
deviation of the observed mean action potential












at P * 0.05
Table 51
Relationship between serum protein bound iodine and the
deviation of the observed mean action potential
duration from the predicted















at P » 0.05
Table 32
Deltoid. Thyrotoxic patients.
Relationship between weight loss and the deviation of the
observed mean action potential duration from the











at P a 0.05
Rectus femoris. Thyrotoxic patients.
Relationship between weight loss and the deviation of the
observed mean action potential duration from the












at P » 0.05
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those patients who had clinical weakness of the deltoid muscle as
compared with those who had none (Table 34). Although the dif¬
ference between the two groups was even larger in patients whose
rectus femoris was examined clinically and electromyographically,
a statistical analysis did not reveal this as being significant,
probably because of the smaller number of patients (5 out of 24)
who exhibited weakness of this muscle. (Appendix Table 15)
Extent of Muscle Involvement. If the degree of EMG- change
was compared with the extent of the involvement of the muscles by
weakness and/or atrophy, it can be seen from Table 35 that there
was a significant difference between those patients who had proximal
involvement and those who had none. Moreover, there was an even
greater difference between those patients who had weakness and
atrophy of the distal as well as the proximal muscles compared with
those who had no muscle involvement. (Appendix Table 11)
Herve Conduction Velocities and Latencies
(Appendix Table 9)
Tables 36 and 37 show that there were no significant dif¬
ferences in 12 patients between the conduction velocities in the
ulnar nerve, measured from the elbow to the wrist, or in the laten¬
cies from the wrist to the abductor digiti quinti as compared with
the results for controls.
Muscle Biopsy
Thirty patients had a muscle biopsy carried out, and the
results are shown in Table 38. Only 14 of the sections were found
to be suitable for an estimation of mean fibre diameter and fibre
population per square mm., largely because of the difficulty in
Table54







































































The results of muscle biopsy on 30 thyrotoxic patients.
• Muscle libre diameter (p ) No. fibres
per m.m.2
"
Case No. biopsied Total No.
*
Mean Histology-
1 Delt. 4389 77 57 136 Normal
2 Rect. fem 4326 103 42 329 Normal
3 Triceps 4C40 101 40 482 Normal
4 Delt. - - - - Normal
5 Rect. fem 4LQ0 100 4L 388 Normal
6 Rect. fem - mm - - Normal
7 Rect. fem - - - - Infiltration of fat between muscle
fibres.
8 Rect. fem - - - - Normal
10 Delt. - - - - Proliferation of connective tissue
between muscle bundles
11 Delt. - mm - - Normal
12 Delt. - mm mm - One lyiaphorrhage
13 Delt. 4264 104 4L 449 Two lymphorrhag e 3
15 Delt. 3900 100 39 487 Degenerating fibres with macrophages
and lymphocytes.
16 Rect. fem 4284 102 42 4L3 Normal
18 Delt. 3978 102 39 429 Normal
19 Delt. - - - mm One degenerating fibre with macrophages
24 Delt. 3740 85 44 426 Normal
25 Delt. - - mm mm Normal
29 Delt. mm - - - Normal
30 Delt. - - mm - Normal
31 Delt. - - - mm Normal
36 Rect. fem 3230 85 38 396 Normal
37 Delt. 2640 66 40 290 Normal
38 Delt. 2482 73 34 - Normal
39 Rect. fem 3627 93 39 554 One lymphorrage
40 Rect. fem - - - - Normal
u Rect. fem - - - mm Normal
43 I Rect. fem
J
- - mm - Normal
47 Rect. fem - - mm - Normal
48 Delt. 3589 97 37 446 Normal
Mean u 398
Belt. - Deltoid
Rect. fem = Rectus femcris
43
getting an exact cross-section. Table 39 lays out the results of
those control biopsies which were judged to be adequate for measure¬
ment.
Pig. 12 shows that, apart from one patient, all the thyro¬
toxics had mean muscle fibre diameters which were, on average, 12
microns smaller than those of the controls (Pigs. 13, 14, 15, 16).
No statistical analysis has been done because the biopsies were
carried out on different muscles.
Pig. 17 demonstrates the increased number of muscle fibres
per 3quare mm. in the thyrotoxic patients compared with the control
subjects (mean 398 and 287/square mm. respectively). The infer¬
ence is that when the muscle fibres become smaller they get more
crowded together.
Histology. Seven out of the 30 patients (23.3$), apart from
any reduction in fibre diameter, also had some histological abnor¬
mality. Many showed an apparent increase in sarcolemmal nuclei
(Pigs. 18 and 19) due to the crowding together of atrophied fibres.
However, when cross-seotions were examined the number of nuclei
per fibre was not found to exoeed the upper limit of normal of 8
(Pig. 20).
Degenerating muscle fibres, infiltrated with macrophages and
lymphocytes, were seen in 2 patients (Pig. 21). Pour perivascular
lymphorrhages were seen (Pig3. 22, 23 and 24) and the other histo¬
logical changes were confined to the infiltration of fatty tissue
between the muscle fibres of one patient (Pig. 25) and the pro¬
liferation of connective tissue between the muscle bundles in
another (Pig. 26).
TtBlii 39
The results of ousels biopsy m control adjects*
feusele •itre dia-«tor (V,
Ha of
fibres
Ho. AgS Box Condition biopsied total Ho. : eon per a a£
1 51 M Ktarsal colt. 5050 101 50 243
2 49 X Norfflsl Colt. 4080 80 51 231
3 37 F Variocae veins Sort. 3920 98 40 455
4 33 F varicose veins • nod. 3253 103 31 * 287
5 22 X Various# rains sort* 4717 89 53 343
6 54 % Inguinal hernia art. >300 100 53 194
7 37 X Cydrocoele sort. >616 104 54 305
8 43 M Faricose veins dd. W 3845 63 61 266
9 33 X Inguinal hernia Sort. 4350 91 50
10 57 X Varicose veins art. 3187 91 57 292
11 27 X Inguinal hernia Sort* 4310 82 55 323
12 57 X Inguinal hernia Cart. 4828 89 52 302





v. sod. *. Vastus sredi&lis.
£&rt* * artortus.
dd. I.. a «Muator longus.
MUSCLEFIBRDIAMETER(MICRONS) ojaui*«gQO xx
Fig. 13» Cas® No. 5. Mean muscle fibre diameter
41 P (H. and E., x 475)
Fig. 14. Control biopsy No. 7» Mean muscle fibre diameter
54 n (H. and E.f x 475)
Fig. 15* Case No. 48. Mean muscle fibre diameter.
37 m (H. and E., x 475)
Fig. 16. Control biopsy No. 10. Mean musole fibre diameter





















Fig. 17. Showing differences in the number of muscle fibres per
square mo. between thyrotoxic patients and control subjects.
Fig. 18. Case No. 15* Longitudinal section showing an apparent
increase in aarcolemaal nuclei (H. and S., x 475)
Tig. 19* Control biopsy No. 13* Longitudinal section showing a
normal number of sarcoleamal nuclei (H. and E., x 475)
Fig. 26. Case No. 10. Proliferation of connective tissue
between muscle bundles (Van Gieson, x 75)*
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No comment is made on the presence or absence of muscle
fibre striations, because it cannot be said with oertainty that
striations are absent unless the section is specially stained or
«
is examined tinder polarised light.
There was no significant difference in the EMG- changes
between those who had abnormal histology and those without
(Table 40).
Follow-up Studies (Appendix Table 1ft)
Clinical State. All the patients except two were followed
up by the author, and at the time of writing they are euthyroid.
The average time taken to become euthyroid was 2.1 months from the
start of treatment. Muscle power had returned to normal in about
the same time (mean 2.2 months), but musole atrophy took a signifi¬
cantly greater time (mean 2.8 months, t = 2.290, 0.025 > P > 0.02)
to disappear after the patient had beoome euthyroid.
Degree of Froptosis (Appendix Tables j and 10). Between
the time the patient was first seen and a time four months after
he or she had become euthyroid, serial measurements with the exoph-
thalmometer of the degree of proptosis showed a mean increase of
1.5 mm. in 31 patients, taking the average for both eyes. In 9
patients the eyes had reoeded by a mean of 1.2 mm. and in a further
6 there was no change.
Creatine and Creatinine Ibccretion (Appendix Table 10)
Creatine excretion was measured in 8 male patients four
months after they had become euthyroid. All the values lay within
the normal range of 0 - 200 mg./24 hours and had a mean of
s
Table40
Relationshipb tweenthprese ceofbnormalhis logydd iati n observedm anactiopot ntialdurafr mthredicted (seeTabl s10,6and38).
Histolo^















48,5 i 26,2 mg./24 hours. Four of the 23 women in whoa creatine
excretion was estimated had values just above the upper limit of
normal. The mean for women was 98 & 85.1 mg./24 hours.
Creatinine excretion, studied on the same patients, showed
that all the men except one (0.820 g./24 hours) had values lying
within the normal range of 1.0 to 2.4 6.> with a mean of 1.368 ±
0.033 g»/24 hours. Only 3 of the women had creatininuria in
excess of the upper limit of normal of 1.3 g. The mean value for
creatinine excretion in the women was 1,046 ± 0.031 g./24 hours.
Electromyography
Thirty-six patients had electromyograms repeated on the
same muscles as before. The follow-up EMG-'s were done four months
after the patients had beoome euthyroid.
Deltoid (Appendix Tables 4 and 5)
Action Potential Duration. Table 41 and Fig. 27 show that
14 out of the 21 patients (66.6$) on whom EMG-'s were repeated had
an action potential duration which did not differ significantly
from the predicted for their age. Six patients (28.6$) were still
below the lower limit of normal, but had improved considerably on
their original action potential duration. One patient developed
a duration which was significantly above the upper limit of normal.
Id making the calculations, the assumption was made that the
patients were still the same age as at the time of their first EMG-.
In faot, the majority of patients had their follow-up EMG done
7-9 months later, and the longest interval was 11 months. Any
error caused by this in calculating the predicted action potential
duration would not be more than 0.1 m. sec.
IO 20 30 40 SO 6O 70 SO
AGE (YEARS)
Jig. 27. Deltoid. Follow-up eleotromyograms. Graph showing
the relationship between age and nean action potential duration
in patients and controls.
TABLE 41
Pbllow-up electronyograms. Deltoid
Table showing the deviation of the observed mean action

















Statistical significance of deviation
t P
1 42 9.7 12.0 -2.3 4.862 PC 0.001
4 47 11.9 12.2 -0.3 0.636 0.6>P>0.5
10 38 11.1 11.8 —0.7 1.486 0.2>P>0,1
11 50 12.4 12.4 0 0 0
12 48 12.6 12.3 +0.3 0.632 0.6>P>0.5
13 32 12.3 11.5 +0.8 1.687 0.2>P>0.1
14 26 10.7 11.2 -0.5 1.046 0.4>P^0.3
17 69 11.6 13.3 -1.7 3.462 0.005>p>0.001
18 64 11.2 13.1 -1.9 3.925 I* 0.001
19 66 12.3 13.2 -0.9 1.848 0.1>P>0.05
20 39 12.2 11.9 +0.3 0.636 0.6>p>0.5
22 38 13.0 11.8 +1.2 2.547 0.02?P>0.01
25 55 13.4 12.6 +0.8 1.684 0.2>P>0.1
29 53 11.6 12.5 -0.9 1.898 0.1>P70.05
30 49 11.6 12.3 - 0.7 1.521 0.2>P?0.1
31 50 12.1 12.4 -0.3 0.635 0.6>P?O.5
32 52 11.3 12.5 -1.2 2.531 0.025>PX).02
37 36 11.7 11.7 0 0 0
38 58 9.8 12.8 -3.0 6.276 P<0.001
45 55 11.6 12.6 -1.0 2.100 0.05>P>0.025
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Action Potential Amplitude. The mean amplitude in the follow-
up EM&'s done on the deltoid showed no significant difference from
that of the controls (Table 42). However, there had been a
statistically significant increase in amplitude (137.8 hV) in the
EMG-'s (Table 43) compared with those done before the start of treat¬
ment (95.8 UV).
Polyphasic Potentials. The mean percentage of polyphasic
potentials in the follow-up EKG-'s was not markedly different from
that of the controls (Table 44) and showed a highly significant
reduction compared with the records taken previously (Table 45).
Spontaneous Activity. One fibrillation potential was found
in the EM& of Case No, 37.
TjHectromyof-'ram on Maximal Volition. An interference pattern
was found in all the cases and the voltage was not significantly
different from that of the controls (Table 46 and Appendix Tables
4 and 7),
Rectus Femoris
Action Potential Duration. Of the 15 electromyograms done
on euthyroid patients, all had action potential durations which
were normal (86.7^), except for one which was significantly below
the predicted and another which was just above the upper limit of
normal (Table 47 and Fig. 28).
Action Potential Amplitude. Comparison of the mean ampli¬
tude of the follow-up SM&'s showed no significant increase on the
pre-treatment values (Table 48). Ih fact, there was a slight
Table42
Follow-upe ectron^ograms.D ltoid.









































































Fig. 28. Rectus femoria. Follow-up electromyograms. Graph
showing the relationship between age and mean action potential































































































































reduction, and the amplitude was not statistically different from
that of the controls (Table 49).
1-olyphasic Potentials. Following successful treatment of
the thyrotoxicosis, the EKG-'s done on the rectus femoris revealed
no significant reduction in the percentage polyphasicity, compared
with the previous values (Table 50), and there remained a differ¬
ence between the patients and the oontrols in this respect (Table
51).
Spontaneous Activity. No fibrillation potentials or
fasciculations were seen in the EMtt's done on the rectus femoris
of euthyroid patients.
Slectromyofiraa on Maximal Volition (Appendix Table 7). An
interference pattern was obtained in all cases with a voltage which
did not differ significantly from that of the controls (Table 52).
Triceps
A comparison of Table 53 with Table 21 will show that the
action potential duration returned to a level similar to that of
the two controls, as did the degree of polyphasicity. Although
the mean amplitude rose from 113 uV to 130 pV, it is not known
whether or not this is significant.
Table49
Follow-upalectr myograina:Re tusfe ris.













Follow-upelectromyograms:R ctusfera ri .

















Follow-upelectromyograms:R ctusfem ri .













































































(1) The average age of onset of thyrotoxicosis was the same
for men as for women.
(2) Fifty per cent of the patients had some complaint of
weakness, and there was no sex difference in this respect.
(3) 3.7$ had weakness as a presenting symptom.
(4) Proximal muscles alone were affected in 63. G$ of the
patients. Proximal and distal muscles together were involved in
a further 18.5$.
(5) In no case were distal muscles solely affected. No
Oases of bulbar muscle vreakness were seen.
(6) Extensor muscles were involved twice as commonly as
flexor muscles.
(7) No significant increase in strength developed following
the intravenous injection of edrophonium (Tensilon).
Biochemistry:
(1) No consistent abnormalities were found in the serum
levels of calcium or potassium.
(2) The mean two hour' post-prandial glucose level was raised,
indioating a generally diminished tolerance to ingested glucose.
(3) There was usually an increase in urinary creatine
excretion and a reduction in creatinine, compared with normal.
Electromyography;
(1) Fifty out of the fifty-four patients (92.6$) showed a
reduction in the mean action potential duration in the proximal
muscle sampled.
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(2) There was no significant change in mean action potential
amplitude.
(3) A general increase in the percentage of polyphasic poten¬
tials was noted in all three muscles sampled.
(4) Spontaneous activity was inconspicuous, fibrillation and
fasciculation being found only once.
(5) Full effort almost always produced a normal interference
pattern, though a mixed pattern wa3 seen in three patients. A
reduced mean voltage was seen in the MC-'s of the rectus femoris.
(6) 42.9$ of the 21 patients tested had an abnormal eleotro-
myogram of the abduotor digiti quinti, and all of these had a gross
abnormality of the proximal muscle sampled. Fasciculation and
fibrillation was seen in three patients each.
(7) The deviation of the action potential duration was greater
in those patients who had clinical weakness of the deltoid muscle
than in those without. This relationship was not apparent in the
rectus femoris.
(8) The severity of the EM& changes correlated well with the
extent of the muscle involvement.
Nerve Conduction Velocities and Latencies:
No abnormality was seen.
Muscle Biopsy:
(1) There was a general reduotion in fibre diameter in the
thyrotoxic patients, accompanied by an increase in the number of
fibres per unit area.
(2) Abnormal histology was found in 23»3% of the biopsies.
- 50 -
Follow-up:
(1) The time taken for normal strength to return and for the
euthyroid state to be achieved was the same. Muscle atrophy took
a little longer to recover.
(2) Creatine and creatinine excretion returned to normal in
nearly all patients.
(3) Only 19$ of the SMG-'s done on the euthyroid patients had
an action potential duration which was significantly different from
the predicted. There was a significant increase in amplitude in
the deltoid muscle, but the mean wa3 still within the normal range.
The percentage of polyphasic potentials had returned to normal in
the deltoid and triceps muscles, but remained elevated in the EMG-'s
done on rectus femoris.
_ 51 -
DISCUSSION
The findings of this study of 54 unselected thyrotoxic patients
suggest that a muscular lesion, either apparent or subclinical, is
almost a constant feature of hyperthyroidism. The evidence for
this rests mainly on the clinical investigation and on the
results of electromyography. The histological examination of
muscle tissue, while suggestive, did not provide quite such conclu¬
sive evidence.
Clinical Aspects
The clinical findings in these patients were strikingly similar
to those found by an analysis of the 73 cases of chronic thyrotoxic
myopathy described in the literature (compare Tables 1 and 3).
The mean age of patients with myopathy was not significantly
different from that of the present unselected thyrotoxics and pro¬
vided no foundation for the popularly held belief that the muscular
lesion of hyperthyroidism is more common in the older age groups
(Thorn and Sder 1946, Grob 1963a). No sex difference was discern¬
ible in the age of onset of thyrotoxicosis, either in the reported
oases or in the present series.
From the frequency with which cases of chronic thyrotoxic
myopathy have been reported, it would appear that the condition is
more common in males than females. Thirty eight cases have been
described in males as compared with 35 in females. This gives an
almost 1s1 ratio, in oontrast to the usual preponderance of four
female patients to one male (Williams 1962, p. 170). In this
study the women outnumbered the men by 2.9:1. There are several
possible explanations for the relatively more frequent occurrence
- 52 -
of male cases of thyrotoxic myopathy in the literature. The
first is that the muscles of men may differ in some way from those
of women, but there is no histological or biochemical evidence to
support this. The second is that females have proportionately more
fat and less muscle in their bodies than men (Staffurth 1962).
Consequently it might be expeoted that, following the onset of
thyrotoxicosis, there would be a greater protein sparing effect in
women than in men. A third is that men are more usually engaged
in heavy physical exertion than are women and hence their weakness
would tend to make them seek medical attention rather more than
women. That this might be a factor is suggested by the much
longer history of the illness in the female patients described in
the literature.
The mean weight loss in the reported cases was twice that
found in the present study and oould be accounted for by the much
greater duration of thyrotoxicosis.
Distal musoles and bulbar involvement were seen more often
in the cases described in the literature (42.3$ and 16.4$) than in
the un3elected patients (18.5$ and 0$), but this too may be merely
a reflection of the longer history of the condition.
A goitre was present in 87$ of the reported cases of chronic
thyrotoxic myopathy which is not significantly different from the
incidence of 92.6$ found in the patients studied, nor was there any
real variation in the incidence of ophthalmoplegia in the two groups
of patients, being 5.5$ in the reported cases and 7.4$ in the
present series. G-lucose tolerance was equally diminished in both
groups, though only a small number of the patients in the litera¬
ture had had specific investigations for this carried out. No
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striking abnormalities in the serum levels of calcium and potassium
were noted in the present study.
There were increased amounts of creatine and decreased
amounts of creatinine in the urine of both groups of patients.
The changes in the quantity of creatine excreted were slightly less
marked in the reported cases of myopathy, in some cases of which
creatinuria was very low or totally absent (Zierler 1951). Grob
(1963a) has already pointed out this tendency for creatinuria to
diminish as the muscle involvement becomes more manifest and Hoch
(1962) has suggested that it is probably due to a failure of syn¬
thesis of creatine.
Though the muscles were, obviously, not so frequently involved
as in the cases cited in the literature, 5C$ of the patients in this
study had some complaint of muscle weakness and in 3.7$ it was, in
fact, the presenting symptom. The most characteristic complaints
were those of difficulty in going upstairs or lifting the arms
above the head as had been described before in cases of thyrotoxic
myopathy (Parsons and Twort 1939, Thorn and Eder 194-6, Millikan and
Haines 1953, Hoffenburg and Eales 1956, Hed, Kirstein and Lundmark
1958, 'Whitfield and Hudson 1961). Some of the patients had also
noticed weakness and aching in the thighs, even when walking along
the level.
On examination no fewer than 81.5$ of the patients were found
to have some involvement of their muscles. Usually this was a com¬
bination of both wasting and weakness, but in a few there was mild
atrophy without demonstrable I03S of strength and in a larger number
there was weakness without any diminution in muscle bulk.
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Reoently two surveys on the 3ame subject as this thesis have
been published by workers in London and Tokyo (Havard, Campbell,
Ross and Spence 1963, Satoyoshi et al 1963) and their conclusions
correspond quite well with those of artioles written a few years
before about smaller numbers of patients (Pipberger et al 1955,
Hed et al 1958, Gimlette 1959). The results, together with those

















20 15?? - 55%
Gimlette
1959
AO - 32.5# 60%
Havard
et al 1963 50 6% 34?? 80%
Satoyoshi
et al 1963 240
- - 61%
Present
series 54 3.7% 5<$ 81.5%
Considering that the patients are drawn from so far afield as
Sweden, Switzerland, Britain and Japan, and taking into account
variation in the criteria for clinical weakness, there is a remark¬
able uniformity in the figures and, on this evidence, that there
is loss of muscle power in a majority of patients with hyper¬
thyroidism must be acoepted.
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A striking feature in both the cases recorded as "chronic
thyrotoxic myopathy" and in the survey of Havard et al (19^3 )» as
well as the present one, has been the prediliction for proximal
muscles. Havard and his colleagues found that the deltoid, supra-
•pinatus and the quadriceps were the most commonly involved musoles.
In this series the muscles most often affected were those of the
shoulder girdle and upper arm, the pelvic girdle and thigh muscles
being less frequently involved as can be seen from Table 6. In
order of incidence, the most severely affected muscles were the
supraspinatus, triceps, deltoid, infraspinatus, biceps brachii,
iliopsoas and the glutei . Extensor muscles were twice as commonly
affected as flexor muscles.
In 18.59? of the patients distal muscles, always of the fore¬
arm and hand, and never of the leg or foot, were wasted and weak
in addition to the involvement of the proximal muscles and in no
ease was a distal muscle involved alone. This situation was also
noted in the 73 cases summarised in Table 1, but was more marked.
In the cases cited in the literature a moderate incidence of bulbar
symptoms occurred. This was not found in the present series.
This march of events - first proximal, then distal, then bulbar
muscle - suggests a difference in susceptibility of each type of
muscle to the thyrotoxic process. Muscles which are used most for
prolonged effort and the maintenance of posture have a higher pro¬
portion of red fibres than those which have as their function short
bursts of activity. Moreover "the more rapidly contracting flexor
muscles in most mammals tend to be more pale than the extensors"
(Adams et al 19&2, p. 99)* Red muscle is known to have a much
- 56 -
greater number of mitochondria than white muscle (Lawrie 1953)> a
fact which is of great significance, since mitochondria contain
the mechanism for the production of energy by oxidative phosphory¬
lation. The muscles more capable of quick movement, that i3
flexor muscles, with proportionately more white fibres and fewer
mitochondria, obtain their energy from anaerobic glycolysis to a
greater extent. The connection between mitochondria, muscle
weakness and thyrotoxicosis will be discussed later.
Electromyography
Previous reports of electromyography in thyrotoxic patients
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All the articles in the literature to date have been about
.!
qualitative estimations of the electromyographic findings in thyro¬
toxicosis and any difference in the results so obtained could be
due to observer error. However, apart from the results of
Satoyoshi et al (19&3)> four previous reports are remarkably
similar (Pipberger et al 1955, Hed et al 1958, Yates 19&2, Havard
et al 1963). Presumably the finding by Killikan and Haines (1953)
of normal electromyograms in several cases of thyrotoxic myopathy
must be explained by the different criteria employed by workers in
the past for the visual interpretation of the electromyogram.
The results of the present series show that nearly all thyro¬
toxic patients, whatever the severity or duration of their illness
and no matter what their age, have some evidenoe of myopathy in
their proximal muscles, as defined by a significant reduction in
the mean action potential duration on minimal effort. This
criterion for the diagnosis of a myopathy, first described by
Kugelberg (1947, 1949), has been confirmed by several authors
(Pinelli and Buchthal 1953, Buththal and Finelli 1953, Eaton and
Lambert 1957). It must be emphasized, however, that this reduction
is in no way specific for thyrotoxicosis, for it occurs in any
primary lesion of muscle such as muscular dystrophy, polymyositis
or dystrophia myotonica (Pinelli and Buchthal 1953, Buchthal and
Pinelli 1953). It has not been noted in patients with disuse
atrophy resulting from one to six months' immobilisation (Buchthal
1957).
Although the voltage of the potentials on minimal effort in
the present series was generally diminished, a statistical analysis
of the results did not reveal that they were significantly lower
than the control values. This finding; is not in accord with that
of Buchthal (1957) who found a decrease in amplitude of the poten¬
tials on minimal contraction. This discrepancy may however be
explained by differences in the severity of the muscle lesion, for
his examination was performed on patients labelled as "chronic
thyrotoxic myopathy", while the present study was on consecutive
patients suffering from thyrotoxicosis. Buchthal has himself
pointed out (1957) that the mean amplitude must deviate from the
normal by more than 50J& in order to become statistically signifi¬
cant.
Taking all the patients as a whole the mean percentage of
polyphasic potentials was higher than in the control subjects, but,
as oan be seen from Pig.5 there was a considerable overlap in
results. This increase in polyphasic potentials is a character¬
istic feature of a myopathy (Kugelberg 1949).
The pattern on maximal effort was nearly always of the inter¬
ference variety, though a mixed pattern was seen on three occasions.
The voltage of the interference pattern was generally reduced, com¬
pared with controls, though this relationship was only shown to be
significant in the electromyograms done on the rectus femoria. A
reduction in the peak to peak voltage of the interference pattern
has been found in myopathies in general (Kugelberg 1947# 1949) and
in thyrotoxicosis in particular (Hed et al 1958).
Spontaneous activity, in the form of fibrillation potentials
and fasoiculation was rarely seen, each being found in the proximal
muscles sampled in only one patient. This is in agreement with
the findings of Hed et al (1958) and of Havard and his colleagues
(1963). Relatively more fascicul&tion and fibrillation was seen
- 59 -
in abductor digiti quinti. The comparative absence of spontaneous
activity in the thyrotoxic patients reflects the paucity of similar
reports in the literature on thyrotoxic myopathy.
Less than half of the patients tested (4-2.9$) had a signifi¬
cantly reduced mean action potential duration in their abductor
digiti quinti and all of these had evidence of proximal muscular
involvement. This tendency for the proximal muscles to be more
severely affected electromyographioally than the distal muscles has
also been noted by Pipberger et al (1955). Thus the electro¬
myographic findings reflected the clinical picture, the proximal
muscles being involved in the majority and the distal muscles being
affected to a lesser extent and in a smaller number of patients.
There is still no completely adequate explanation of the
factors which determine the action potential duration in myopathies.
Buchthal and Rosenfalck (1955) pointed out that in normal muscle
the longer duration of the motor unit potential compared with that
of the individual fibre was due to a temporal dispersion in the
summation of the fibres of the motor unit and they suggested that
differences in temporal dispersion could be esqplained by variations
in the size of the end plate region. Peinstein, LindegErd, Nyman
and Wohlfart (1954-) had earlier corns to the conclusion that the
degree of scatter of fibres of a motor unit could be expected to
play a large part in determining the action potential duration
recorded on the electromyograph. The short durations recorded in
muscles such as the abduotor digiti quinti, compared with biceps
braohii (Sacoo, Buchthal and Rosenfalck 1962), could probably be
explained on this basis. Sacco et al postulated that the pro¬
gressive increase in action potential with age after the age of 20
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in most muscles was due to a decrease in muscle volume with advanc¬
ing years, leading to a closer crowding together of muscle fibres.
This would cause the voltage of the initial and terminal components
of the motor unit potential, normally picked up from fibres of sub-
units lying more than 0.5 mm. from the electrode, to be greater and
thus more easily recorded. However, they were unable to explain
why this increase in duration with age did not occur in the
abductor digiti quinti.
The shorter action potential duration in myopathies has been
attributed to the decrease in the number of fibres in each subunit
(Buchthal and Rosenfalck 1963). This might have the effect of
rendering those potentials emanating from distant subunits undetect¬
able to the recording electrode. Theoretically, atrophy of muscle
fibres and a resultant higher density per unit area would be
expected to reverse this effect. In the present study there was
an almost constant reduction in fibre population, yet the action
potential duration was shortened in all cases. Assuming ohat the
tendency for the voltage to be lowered both on minimal and maximal
effort was true, since Hakansson (1956, 1957) has shown that the
voltage of single muscle fibres varies as the square of their
diameter, then the reduced action potential found in the present
study must have been due to a decrease in the number of functioning
fibres.
The increased number of polyphasic potentials, a well-known
feature in myopathies, could be due to one of two causes, or both,
A motor unit, which in the healthy patient gave rise to a long
action -potential duration, owing to the large temporal dispersion
of subunit potentials, would be expected to show a polyphasic outline
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if the number of fibres in each subunit was reduced in an irregular
fashion (Buchthal and Rosenfalck 1963)• Sprouting of the terminal
nerve fibres in the thyrotoxic myopathy described by Coers and Woolf
(1959» p. 118), and not yet confirmed, might also give rise to a
raised incidence of polyphasic potentials by causing greater temporal
dispersion, due to slower conduction through immature nerve fibres
(Buehthal and Rosenfalok 1963).
When the presence or absence of clinical weakness in the muscle
sampled was compared with the magnitude of the reduction in mean action
potential duration, it was found that those patients with loss of muscle
power in the deltoid had significantly greater EMG changes than those
without. The same relationship could not be shown to be statistically
significant in the rectus femoris muscle, probably because of the small
number of persons with weakness of the quadriceps group.
The reduction in action potential duration was greatest in those
patients with the widest extent of muscular involvement (proximal and
distal). Patients with weakness and wasting of proximal muscles only
had a smaller reduotion. Compared with those with clinically normal
musoles, the EMG- changes in the first two groups were statistically sig¬
nificant, being more so in the group more extensively affected.
Nerve Conduction
No abnormalities were found of conduction velocity in the ulnar
nerve or of latency at the wrist, despite the report by Havard et al.
(1963) of swelling and beading in the terminal nerve fibres and clubbing
of the motor end plates.
Muscle Biopsy
The results of biopsy show that there was an almost constant
reduction (23$) in the diameter of the muscle fibre with a mean of
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12 microns, and a consequent higher density per unit area. This find¬
ing has not been reported before, although numerous authors have described
patchy atrophy of fibres (Morgan and Williams 1940, Bartela and Pizer 1944,
Thorn and Edor 1946, Hoffenburg and Bales 1956, Bostrom and Hed 1958, Hed
et al 1958, Whitfield and Hudson 1961, Havard 1962, Satoyoshi et al 1963).
It is possible that in many of the reports in the literature the increase
in sarcolemmal nuclei was more apparent than real, due to the higher
density of muscle fibres. In the present series no patients appeared to
have an absolute increase of more than 8 nuclei per fibre on cross section
(Adams et al 1962, p. 19)*
Muscle histology has been variable in the cases of chronic thyro¬
toxic myopathy reported in the literature. Thus normal biopsies have
been reported by Morgan and Williams (1940), Sanderson and Adey (1949),
Millikan and Haines (1953), Kite et al (1954), Collings and Lienhard (1957)
and Melville (1959), whereas there have been a rather greater number of
descriptions of pathological changes in muscle (Morgan and Williams 1940,
Bartels and Pizer 1944, Thorn and Sder 1946, Devic et al 1947, Quinn and
Worcester 1951, Whitfield and Hudson 1961, Havard 1962). These
changes have been variable but have usually included, in addition
to increase in sarcolemmal nuclei, fatty infiltration between the
muscle fibres, fibrous replacement of muscle tissue, aggregations of
lymphocytes (lymphorrhages), vaouolisation and degeneration of isolated
muscle fibres with phagocytosis. In addition, Devic et al (1947)
found changes in the structure of mitochondria in the region of the
motor end plate. Although Havard et al (1963) reported no histo-
pathology in 48 biopsies done on unseleoted thyrotoxic patients, Hed
et al (1958) found abnormalities in 17 out of 18 oases and Satoyoshi
and his oolleagues (1963) noted scattered pathological changes of
varying degree in 68$ of their biopsies. Apart from a reduction in
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the diameter of muscle fibres, histological abnormalities were found
in 23«3$ of the 30 biopsies in the present series. The changes
inoluded degeneration of isolated fibres with macrophage and lympho¬
cyte infiltration, infiltration of fat between muscle fibres, connec¬
tive tissue proliferation and focal perivascular collections of
lymphocytes (lymphorrages).
The pathology observed by Dudgeon and Urquhart (1926) in the
eye musoles of patients suffering from malignant exophthalmos was
also found in various skeletal musoles and was very similar to that
described in thyrotoxic myopathy. It is possible that the histo¬
logical lesions are produced by excess thyrotropin or "exophthalmos-
preducing substance" (Kinderen et al 1960). Some evidence that
these changes can be produced by antuitrin T in the absence of
thyroxine was provided by Paulson (1939) using thyroideetomised
guinea-pigs. This work was confirmed later by Dobyns (1946). Of
the 7 patients each with abnormal histology in the present series,
2 had marked bilateral exophthalmos, 3 had unilateral exophthalmos,
one had moderate ophthalmoplegia without proptosis and only one had
no eye involvement.
If an anterior pituitary factor does produce these histological
i,
changes, it seems unlikely that the lesions are the cause of thyro¬
toxic myopathy, since as soon as the level of circulating thyroxine
is reduced to a normal level, by whatever form of treatment, the
patient's strength returns and atrophy disappears, despite the
general inorease in proptosis (see Results) and the rarer development
of ophthalmoplegia, sometimes accompanied by pretibial myxoedema and




The time taken for the patient to regain normal strength was
the same as that for the achievement of euthyroidism. This
suggests that the weakness was closely related to the presence of
excess thyroxine and not to anterior pituitary factors. Muscle
hulk took a little longer to return to normal. This might indicate
that the muscle atrophy was not the direct cause of the weakness,
hut was secondary to some biochemical malfunction of the muscle
fibres. The association of weakness without wasting was often
seen in the patients, while the converse was rare.
Within a period of four months following euthyroidism, nearly
all patients had normal creatine and creatinine metabolism as
evidenced by their levels of excretion in the urine.
3h parallel with the clinical recovery of the patients, the
follow-up studies showed that 81$ of the patients had a return to
normal of their mean action potential duration, and of those whose
duration was still significantly reduced all showed considerable
improvement. Sanderson and Mey (1949) also noticed the gradual
return of short potentials to a normal duration during a period of
several months following treatment.
The percentage of polyphasic potentials found in the ERS's of
the deltoid done four months after the achievement of the euthyroid
state showed a general return to the values found in the control
subjects. The persistence of an abnormal percentage of polyphasic
potentials in the records taken from the rectus femoris may indicate
a slower recovery of that muscle from the effects of thyrotoxicosis,
or permanent damage to fibres in large motor units or might even be
due to the effects of the sprouting of terminal nerves which was
seen by Coers and WooIf (1959). Sanderson and Adey (1949) have
also noticed this persistence of polyphasic potentials, despite a
return of the other features of the electromyogram to normal,
The voltage increase of the interference pattern found in the
follow-up EMG's of the rectus femoris suggests that there had been
an increase in the number of functioning fibres following the con¬
trol of the thyrotoxicosis.
The Role of Thyroxine in Myopathy v
An analysis of the cases of chronic thyrotoxic myopathy in the
literature and the results of the present investigation reveal that
on average the symptoms of weakness became apparent one to two
months after the onset of thyrotoxicosis and receded as soon as the
disease was brought under control. That there is a close relation¬
ship between thyroid hormone excess and the production of a myopathy
has been seen in experimental animals (Kavard et al 1963).
Several authors have shown that mitochondria contain the
mechanisms for oxidative phosphorylation and the production of the
high energy phosphate bonds of adenosine triphosphate (Green, Loomis
and Auerbach 1948, Kennedy and lehninger 1949, Harman 1950, Lehninger
1959* Green and Hatefi 1961). The transformation of oxidative to
phosphorylative bond energy has been called "coupling" by Loomis and
Lipmann (1948). Hoch, in a recent article (1962), has made a com¬
prehensive review of the evidence that excess thyroxine produces
uncoupling of oxidative phosphorylation and increases the rate of
oxygen consumption. He also noted the connection between the swel¬
ling of normal mitochondria, when in the presence of an uncoupling
substance, and the swelling of mitochondria in thyrotoxic tissue.
Hoch (1962) postulated that the net effect of thyroxine on oxidative
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phosphorylation was the decreased production of high energy bonds
and the dispersion of energy as heat, a feature characteristic of
hyperthyroidism.
It is known that muscular contraction results from the inter¬
action of actin, myosin and adenosine triphosphate (A.T.P.) in the
muscle fibrils (llommaerts 1963). Consequently, if the amount of
JUT.P. available were diminished, muscular contraction would be
expected to be less effective. This loss of mechanical efficiency
in thyrotoxicosis has already been shown by Plummer and Boothby
(1923) and by Smith and Y/halen (1960). Recently Shinosaki et al
(1963) discovered a direct correlation between loss of muscular
strength and the decreased A.T.P. content of thyrotoxic muscle
obtained by biopsy.
Riosphocreatine is necessary for normal musole contraction.
It8 probable role is in the immediate resynthesis of A.T.P., acting
as the donor of a phosphoryl group to adenosine diphosphate (Thomas
1963» p. 307). A reduction in phosphocreatine was found in thyro¬
toxic muscle by Shinosaki and his oo-workers (1963). This
decrease probably is mediated by the direct inhibiting action of
excess thyroxine on creatine phosphokinase (Askonas 1951)* The
inability of the cell to resynthesize phosphocreatine is reflected
in the raised serum levels (Shinosaki et al 1963) and the increased
urinary excretion of creatine, as well as in the decrease tolerance 0f
thyrotoxic patients to ingested oreatine (Thorn and Eder 194-6,
Wilkins and Fleischmann 1 %-6). An adequate amount of intracellular
potassium may also be a necessary factor for the formation of phos-
phooreatine (G-rob, Liljestrand and Johns 1957» Shinosaki et al 1963).
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Since creatinine is a breakdown product of phosphocreatine,
it is not surprising that its excretion is reduced in thyrotoxic
patients. The finding of a low or absent excretion of creatine in
some patients with myopathy (Zierler 1950 has been attributed by
Hoch (1963) to the failure of synthesis of creatine in the liver
and kidneys. This requires A.T.F. for the transfer of a methyl
group from methionine.
The role of pyridoxins (Wohl, Levy, Szutka and Maldia i960)
and thiamine deficiency (Williams, Egana, Robinson, Asper and du
Toit 1943, Shinosaki et al 1963) in muscle metabolism have not yet
been elucidated,nor is it clear whether the atrophy of muscle
fibres contributes to the muscle weakness of hyperthyroidism, or
is a phenomenon which is secondary to the biochemical dysfunction.
One thing is certain, and that is that the rate of protein syn¬
thesis is decreased in thyrotoxicosis (Hoch 1962).
Intracellular fluid is normally hypertonic with respect to
the extracellular fluid (Reele, Neil and Jepson 1961), and maintains
a high concentration of potassium and a low sodium compared with
the latter. Energy is necessary for the extrusion of water against
an osmotic gradient and for the maintenance of normal concentrations
of potassium and sodium against high diffusion gradients. If the
amount of energy available were diminished by the action of excess
thyroxine, according to Hoch's hypothesis (1962), the selective per¬
meability of the oell membrane might be expected to break down to
acme extent. Green and Matty (1962) have shown that increased
permeability to water is produced by thyroxine. That this also
occurs for other substances may be inferred from the finding in
thyrotoxic muscle fibres of a reduction in potassium of 21$ and a
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doubling of the sodium content, as well as a decrease in aldolase
and lactic dehydrogenase (Shinosaki et al 1963). No information
is available about the intracellular content of chloride in thyro¬
toxic muscle. Total body water has been found to be abnormally
large in some cases of hyperthyroidism (Staffurth 1962), which would
be expected to occur if water diffused across cell membranes.
However, Shinosaki et al (1963) found a slight decrease in intra¬
cellular water in thyrotoxic musole and further work needs to be
done to clear up this point.
The presence in thyrotoxicosis of a low muscle potassium and
a high sodium concentration might explain the connection between
this disease and the hypokalaemie type of periodic paralysis.
McArdle and Merton (1952) and Conn and Streeton (1960) have found
similar abnormalities in the muscle of patients between attacks of
paralysis. A reduoed total exchangeable body potassium also has
been noted in both conditions (Conn and Streeton 1960, Staffurth
1962). It is tempting to suggest that the changes produced in
ttyrotoxic muscle initiate attacks of periodic paralysis in those
who have a latent disposition to it. This also would explain why
the attaoks usually cease once the hyperthyroidism is treated.
No speculation can be made about what effect the ionic changes
in thyrotoxic muscle should have upon the resting membrane poten¬
tial, since the full faots about the intracellular content of water,
chloride and several other ions are not yet known. It should be
possible to measure the resting membrane potential in vivo, as this
already has been done in patients with hypokalaemic periodic paraly¬
sis by Shy» Wanko, Rowley and Engel (1961) and by Creutzfeldt,
Abbott, Fowler and Pearson (1963)*
If any alteration in membrane potential does exist, it also
would affect the motor end plates and thus interrupt neuromuscular
transmission sufficiently to render overt those patients who had a
predisposition to myasthenia gravis. Additional factors linking
myasthenia gravis and thyrotoxicosis depend on the auto-immune
theory first put forward by Simpson (i960). If there was damage
to or alteration in motor end plate structure, as has been described
in thyrotoxicosis (Havard et al 1963), it is conceivable that anti¬
bodies to end-plate receptor protein would be produced by the thymus
The frequency with which the thymus is enlarged in both myasthenia
gravis and thyrotoxicosis has already been remarked upon in the
Introduction to this thesis, and there is some tentative evidence
that antibodies to motor end plate do exist in myasthenia gravis
(Strauss, Seegal, Han, Burkholder, Nastuk and Osserman 19b0, Beutner
Witebsky, Ricken and Adler 19&2).
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SUMMARY AND CONCLUSIONS
A comparison of 73 cases of chronic thyrotoxic myopathy
recorded in the literature with 54 consecutive, unselected thyro¬
toxic patients investigated clinically, electromyographically and
try muscle "biopsy suggests that no real differences are apparent
between the two groups other than those of degree. Fifty per cent
of the patients had some complaint of muscle weakness and, on
examination, 81.5$ had evidence of loss of power, usually accom¬
panied by wasting. There was a marked predeliction for proximal
muscles, especially extensors, distal musoles being involved in
only 18.5$ of the patients. The distal weakness always occurred
in association with involvement of proximal muscles.
92.6$ of the patients showed a significant abnormality in
electromyograms done on proximal muscles. Of the examinations
performed on a distal muscle, abductor digiti quinti, only 42.9$
were abnormal. The criteria employed were a statistically signifi¬
cant reduotion in mean action potential duration, compared with the
predicted for any given age. The mean percentage of polyphasic
potentials in thyrotoxic patients was significantly higher than in
the controls. The amplitude of potentials obtained on minimal
effort was normal, but there was some evidence of a reduction on
maximal effort, when an interference pattern was obtained in all
but 3 cases. These 3 showed a mixed pattern. Spontaneous
activity was an inconspicuous feature of the electromyogram in
thyrotoxicosis. There was a good correlation between the severity
of the electromyographic changes and the extent of the muscular
involvement. No abnormality of nerve function was revealed by
conduction studies.
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Creatine excretion was usually increased and that of creati¬
nine diminished. Serum potassium and calcium estimations were
unremarkable and did not add anything to the investigation.
Muscle biopsies, performed on 30 of the patients, revealed
an almost constant reduction in the size of the muscle fibre. The
mean diameter (41 microns) was 12 microns less in thyrotoxic
patients than in the controls (53 microns) and the fibre population
per square millimetre was raised. Muscle histology was abnormal
in only 23.3$ of the biopsies and the changes were similar to those
already described in the literature.
Pull strength returned as soon as the patients became euthy¬
roid, emphasizing the close relationship between excess thyroid
hormone output and muscular weakness. Electromyograms showed a com¬
plete return to normal in 81$ of the patients and the rest had
improved considerably, although there was a persistently increased
number of polyphasic potentials in some patients. Creatine and
creatinine excretion returned to normal in nearly all cases.
The findings in this study fit in well with the concept of
thyrotoxicosis as a disease of mitochondria, in which there is a
reduction in available adenosine triphosphate, owing to the uncoupl¬
ing of oxidative phosphorylation by excess thyroxine. The muscles
which are richest in mitochondria are those which oontain a prepon¬
derance of red muscle fibres and are used for sustained effort, and
it is these muscles, particularly the extensors, which are the most
commonly affected in thyrotoxicosis. The distal muscles, contain¬
ing largely white fibres and more concerned with quick, infrequent
movements, are less richly supplied with mitochondria and rely
largely on anaerobic glycolysis as a source of energy. These
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muscles were shown to he less frequently involved by weakness and
wasting and to have a much lower incidence of electromyographic
change.
It is suggested that myopathy occurs in virtually all thyro¬
toxic patients, its recognition depending largely on the thorough¬
ness with which muscle weakness is looked for, and on the availa¬
bility of analytical electromyography. The constant nature of
the muscle lesion in thyrotoxicosis and the recently discovered
abnormalities of cell chemistry may explain why both hypokalaemio
periodic paralysis and myasthenia gravis are more common in this
condition than would normally be expected.
REFERENCES
Adams, R. D., Denny-Brown, D., Pearson, C. M. (1962) Diseases of
Muscle. London.
Adrian, E. D., G-elfan, S. (1933) Physiol. (Lond.) 23, 271.
Asboe-Hansen, &., Iversen, K. (1951) Acta endoor. 8, 90.
Absoe-Hansen, Iversen, K., Y/ichmann, R. (1952) Aota endocr.
(Kbh.) 11, 376.
Asboe-Hansen, &., Iversen, K., Wichmann, R. (1953) Ugeskr. Laeg.
115. 894.
Askanazy, M. (1898) Dtsoh. Aroh. Klin. Med. 6l, 118.
Askonas, B. A. (1951) Nature (Lond.) 167. 933.
Auto-analyzer Standard Methods (1960, 1961, 1962) Teobnioon Co.
Ayer, J. B., Means, J. H., Lerman, J. (1934-) Endocrinology, J8, 701.
Bartels, E. C., Piser, E. (1944) Lahey Clin. Bull. 52.
Basedow, C. A. von (1840) Wsohr. ges. Heilk, 6, 197.
Bathurst, L. W. (1895) Lancet, 2, 529.
Bauwens, P. (1955) Proc. roy. Soc. Med. £3, 194.
Berkman, J. M. (1935) Proo. Mayo Clin. 1C), 273.
Beutner, E. H., Yfitebsky, E. Ricken, D., Adler, R. H. (1962)
J. Amer. mad. Ass. 132. 46.
Blahd, W. H., Bauer, F. K., Libby, R. L., Rose, A. S. (1953)
Neurology (Minneap.), 1, 604.
Bostrom, H., Hed, R. (1958) Acta med. scand. 162. 225.
Brain, R. (1959) Lancet, 1, 109.
Buohthal, F. (1957) An Introduction to Electromyography, p 34.
Copenhagen.
Buchthal, F. Guld, C., Rosenfalck, P. (1954) Acta physiol. scand.
12, 200.
Buchthal, F., Guld, C.f Rosenfalck, P. (1955) Acta physiol. scand.
2k» 75.
Buohthal, F., Pinelli, P. (1950 Acta physiol. scand. 2£, Suppl.
82. 13.
- 74 -
Buchthal, F., Pinelli, P. (1953) Neurology (Minneap.) J, 4-24.
Buchthal, F., Rosenfalck, P. (1955) Acta psychiat. scand. JO, 125.
Buohthal, F., Rosenfalck, P. (1963) in "Muscular Dystrophy in Man
and Animals" (edited by G. H. Bourne and M. N. Golarz). Basel.
Buzzard, E. F. (1905) Brain, 28, 438.
Castleman, B., Norris, &. H. (1949) Medicine (Bait.) 23, 27.
Chapman, E. M., Maloof, F. (1956) New Engl. J. Med. 254. 1.
Coers, C., Woolf, A. L. (1959) The Innervation of Muscle, p. 118.
Oxford.
Collings, H., Lienhard, W. F. (1957) Neurology (Minneap.), £, 667.
Conn, J. W., Streeten, D. H. P., (1960) Periodic Paralysis. In
"The Metabolic Basis of Inherited Disease" p. 367. Edited
by J. B. Stanbury, J. B. Wyngaarden and D. S. Frederickson.
New York.
Cohen, B. (1946). S. Afr. med. J. 20, 408.
Cohen, S. J., King, F. H. (1932) Arch. Neurol. Phsohiat. (Chic.)
28, 1338.
Creutzfeldt. 0. D. Abbott, B. C., Fowler, W. M., Pearson, C. M.
(1963) Eleotroenoeph. Clin. Neuro-Physiol. 1J, 508.
Darke, C. S., Hunt, B. W., Brain, W. R., (1938) Guy's Host). Rep.
8£, 121.
Daughaday, W, H., Farr, A. L. (1951) J. olin. Invest. 30. 635.
Del Castillo, E. B., de la Baize, F. A., Caul, H. (1940) Sem. med.
1, 1110.
Devio, A., Froment, R., Guinet, P., Devic, M. (1947). J. Med.
Lyon. 28, 155.
Dobyns, B. W. (1945) Surg. Gyneo. Obstet. 80. 526.
Dobyns, B. M. (1946) Surg. Gynec. Obstet. 82, 609.
Dobyns, B. M. (1950) J. olin. Sndocr. .10, 1202.
Dobyns, B. M., 7Jright, A., Wilson, L. (1961) J. clin. Endocr.
21., 648.
Documenta Geigy (1962), edited by Konrad Diem, p. 530. Manchester.
- 75 -
Dudgeon, L. s., Urquhart, A. L. (1926) Brain, 182.
Eaton, L. M., Lambert, E. H. (1957) J. Amer. med. Asa. 163. 1117.
Ellis, D. S., Caray, (1961) Amer. Practit. 12, 517.
Engel, A. G. (1961) Ainer. J. Med. j£0, 327.
Eppinger, H. (1937) Wien. klin. Wschr. 50, 289.
Fawoett, J. K., Wynn, V. (1961) J. olin. Path. 1^, 463.
Fainstoin, B., Lindegard, B., Nyman, E., Wohlfart, G. (1954)
Acta psychiat. scand. 29. 189.
Flynn, R. (1944) Med. J. Aust. 1_, 344.
Froment, R., Gallavardin, L., Devio, A. (1946) J. Med. Lyon
iZ» 741.
Promant, R., Jeune, M., Duverne, J. (1942) Rev. neurol. (Paris)
lit, 96.
Garoia Austt, E.f Torrents, 1., Musso-Pournier, J. C., (1949)
IVieme Congres Nuerologique International. Vol. I, 77.
Paris.
G-imlette, T. M. D. (1959) Brit. med. J. 2, 1143.
Goldberg, B., Barnett, A. M. (1961) S. Afr. mad. J. 35. 381.
Graves, R. J. (1835) Lond. med. surg. J. 2» 516.
Green, D. E. Hatefi, Y. (1961) Science. 133. 13.
Green, D. E., Loomis, W. P.,, Auerbach, V., (1948) J. biol. Chem.
172. 389.
Green, K., Matty, A. J. (1962) Nature (Lond.). 194, 1190.
Green, R., (1949) Proo. roy. Soo. Med. 42. 263.
Grob, D. (1963a) N.Y, St. J. Med. 6£, 218.
Grob, D. (1963b) Ann. Rev. Med. 1jt, 151.
&rob, D., Liljestrand, A., Johns, R. (1957) Amer. J. Med.
340.
Guld, C. (1951) Acta physiol. scand. 2£, Suppl. 89, 30.
Guy, E., Lefebre, J., Lerique, J., Scherrer, J. (1950) Rev. neurol.
(Paris). 82, 273.
- 76 -
Hakansaon, C. H. (1956) Acta physiol. scand. 37. 14.
Hakansson, C. H. (1957) Acta physiol. scand. 22,* 291.
Harman, J. B., Richardson, A. T. (1954) Lancet. 2, 473.
Harman, J. W. (1950) Exp. Cell. Res. 1.* 382.
Ilavard, C. W. H. (1962) Brit. med. J. 1, 440.
Havard, C. W. H., Campbell, E. D. R., Ross, H. B., Spence, A. ¥.
(1963) Quart. J. Med. J1> 145.
Hed, R., KArstein, L., Lundmark, C., (1958) J. Neurol. Neurosurg,
Paychiat. 21, 270.
Heinrich, W. D., McCabe, E. B., Nicely, D. A., Elder, J. C.,
(1962) Amer. J. Roentgenol. 83. 336.
Hildebrand, A. &., Kepler, E. J. (1941) J. nerv. ment. Dis.
?13.
Hoch, P. L. (1962) New Engl. J. Mea. 266, 498.
Hoffenburg, R., Ealea, L. (1956) S. Afr. med. J. J50, 1246.
Horvath, B., Berg, L., Cummings, D. J., Shy, G. M. (1955)
J. appl. Physiol. 8, 22.
Iversen, K., Asboe-Hansen, 0. (1952) Acta, endocr. (Kbh.)
±L» 111-
Iversen, K.. Asboe-Hansen, &., Carlsen, P. (1953) Acta endocr.
(Kbh.). lifc, 177.
Keele, C. A., Neil, E., Jepaon, J. B. (1961) in Samson Wright's
Applied Physiology, p. 15. London.
Kennedy, E. P., Lehninger, A. L. (1949) J. biol. Chem. 179. 957.
Kinderen, P. J. D., Houtstralans, M., Schwars, P. (1960) J. clin.
Endoor. 20, 712.
Kite, W. C., McLintock, J. C., Graves, R. W. (1954) N.Y. St.
J. Med. 2t> 1613-
Kowallis, G. P., Raines, S. P., Pemberton, J. J. (1942) Arch,
intern. Med. 1942.
Kugelberg, E. (1947) J. Neurol. Neurosurg. Psychiat. 1j), 122.
Kugelberg, E. (1949) J. Neurol. Neurosurg. Psychiat. 12, 129.
- 77 -
Lahey, F. H. (1926) J. Amer. med. Ass. 82, 754.
Laurent, L. P. E. (1944) Lancet. 1_» 37.
Lawrie, R. A. (1953) Bioofcem. J. 305.
Leach, W. (1962) J. Laryng. 2£» 237.
Lehninger, A. L. (1959) P.espiratory-energy transformation. In
"Biophysical Science: A Study Programme". Edited by
J. L. Oncley, F. 0. Sohmitt, R. C. 7/illiams, M. D. Rosenburg
and R. H. Bolt. New York.
Liecbti, H. (1938) Endokrinologie, 20, 81.
Logothetis, J. (1961) Aroh. Neurol. (Ckic.) 523.
Loomis, W. F. and Lipmann, F. (1948) J. biol. Chem. 173. 807.
Ludwig, A. W. Boas, N. F., Soffer, L. I. (1950) Prcc. Soc. exp.
Biol. (N.Y.). 137.
McArdle, B., Merton, P. A. (1952) J. Physiol. (Lond.). 116. 51.
Maclean, B., Wilson, J. A. C. (1954) Lancet. 1, 950.
McCullough, E. P., Claaen, M., Gardner, W. J. (1957) J. clin. Endocr.
12, 1277.
McEachern, D., Parnell, J. L. (1948) J. olin. Endocr. 8, 842.
McEaohern, D., Ross, W. D. (1942) Brain, 6£, 181.
Mackenzie, M. V. (1940) U.S. nav. med. Bull. J58 , 381.
Medical Research Council (1949) War Memorandum No. 7. London.
Melville, I. 13. (1959) Soot. med. J. 318.
Millikan, C. H., Haines, S. F. (1953) Aroh. intern. Med. ^2, 5.
Moersch, F. P., Woltman, H. W. (1956) Proc. Mayo Clin. jil^, 421.
Mommaerts, W. F. H. M. (1963) Araer. J. Med. 35. 606.
Morgan, H. J., Williams, R. H. (1940) Sth. med. J. (Bgham., Ala.)
261 •
Naffziger, H. C. (1932). Discussion of paper by J. L. KcCool and
H. C. Naffziger. Trans. Amer. ophthal. Soc. 103.
Osserman, K. E., Silver, S. (1961) in Transactions of the Fourth
International Goitre Conference (edited by Rosalind
Pitt-Rivers) p. 100. Oxford.
- 78 -
Parsons, F, B., Twort, R. J. (1939) Lanoet. 1, 1379.
Paulson, D. L. (1939) Proc. Mayo Clin. V±, 828.
Pinelli, P., Buohthal, P. (1953) Neurology (Minneap.). 347.
Pipberger, H., Kalin, R., Wegmsnn, T. (1955) Schweiz. med. V/schr.
390.
Plummer, H. S., Boothby, W. M. (1923) Amer. J. Physiol. 6^, 406.
Quinn, E. L., Worcester, R. L. (1951) J. clin. Endoor. 1j>, 1564.
Rowland, L. P., Aranow, H„, Hoefer, F. A. (1957) Neurology
(Minneap,)* Z» 534.
Russell, D. S. (1953) J. Path. Bact. 6£, 279.
Sacco, Buchthal, P., Rosenfalck, P. (1962) Arch. Neurol. (Chio.)
j5, 366.
Saorez, R., Lausecker, C., Isch, C. (1955) Arch, franc. Pddiat.
12, 944.
Sanderson, K. V., Adey, W. R. (1949) Med. J. Aust. 1, 797«
Sanderson, K. V.f Adey, W. R. (1952) J. Neurol. Neurosurg.
Psychiat. 1£, 200.
Sanghvi, L. M., Gupta, K. D., Banerjee, K., Bose, K. (1959) Aner.
J. Med. 2£, 817.
Satoyoshi, E., Murakami, K., Kowa, H., Klnoshita, M., Noguchi, K.,
Hoshina, S., Nishiyama, Y., Ito, K. (1963) Neurology,
(Minneap.). VJ, 645•
Satoyoahi, E., Murakami, K., Torii, J. (1963) Lancet. 2, 843.
Sattler, H., Basedow's Disease, English translation by J. W. and
J. P. Marohand, Grune and Stratton, Inc., New York, 1952.
Sheldon, J. H., Walker, R. M. (1946) Lancet. 1, 342.
Shy, G. M., Wanko, T., Rowley, P. R«, Engel, A. G. (1961).
Exp. Neurol. j>, 53.
Simpson, J. A. (i960) Scot. med. J. j£, 419.
Smith, R. E., Whalen, W. J. (196O) Fed. Proc. 1j?, 175.
Staffurth, J. S. (1962) Metabolism, H, 1274.
Starling, Ii. J., Brain, W. R. (1938) Guy's Hosp. Rep. 88, 117.
- 79 -
Strauss, A. -J. L., Seegal, B. C,, Han, K. S., Burkholdar, P. M.,
Nastuk, W. L., Osserman, K. E. (1962) Proo. Soc. exp. Biol.
(N.Y.). 105, 184.
Strong, J. A. (1949) Banoet, 1., 959.
Talbott, J. H. (1941) Medicine (Bait.). 20, 85.
Thomas, P. K. <1963) in "Clinical Physiology" (edited by S. J. M.
Campbell, C. J. Dickinson and J. D. H. Slater). Oxford.
Thorn, G. W., Eder, H. H. (1946) Amer. J. Med. Jk 583.
Thorn, G. W., Tierney, N. A. (1941) Bull. Johns. Kopk. Hosp.
62, 469.
Thomer, M. W, (1939) Arch, intern. Mad. &j., 330.
Waldenstrom, J. (1945) Acta med. scand. 121. 251.
Werk, E. E., Sholiton, L. J., Marnell, R. T. (1961) Amer. J. Med.
il, 647.
Whitfield, A. G. W., Hudson, W. A. (1961) Quart. J. Med. 257.
Wilkins, L., FLeischmann, W. (1946) J. clin. Invest. 2£, 36O.
Williams, R. H. (1962) in Textbook of Endocrinology (edited by
R. H. Williams). Philadelphia.
Williams, R. H., Egana, E., Robinson, P., Asper, S. P., du Toit, C.
(1943) Arch, intern. Fed. J2, 353.
Wohl, M. G. Levy, H. A., Szutka, A. Meldia, G. (1960) Proc. Soc.
exp. Biol. (N.Y.). 102, 523.
Yates, D. A. H. (1962) "The estimation of mean potential duration
as an index of endocrine myopathy". Paper given at E.E.G.
Society. London. 17 Nov. 1962.
Ziegler, D. K. (1949) Arch, intern. Med. 8^, 419.
Zierler, K. L, (1951) Bull. Johns Hopk. Hosp. 82, 263.
Append!* Table 1



































4.B. 1 42 F Housewife 3 0 0 0 0 0 107 7.5 Brisk Diffuse 8 8
i.m.
Jf
2 48 F Cleaner 4 Legs weak when going
up stairs
11 Quadriceps -H- Infraspinatus ++
Quadriceps -H-
0 122.5 18 Normal Diffuse 18 17
4.L. 1 3 25 F Housewife 7.5 Weakness of thigh
muscles while going
up stairs
8 Triceps ++ Iliopsoas -H-f
Triceps ++
0 133 7 Brisk Diffuse 10 10
E.C. 4 47 M Petrol
checker
1.75 0 0 0 0 0 146 3 Normal Diffuse 15 15








6 22 F Tobacco
worker













Brisk Diffuse 15 15
>


















0 93 19 Normal Nodular 18 18
J.H. 8 37 M Stores
clerk
12 Generalised weakness 5 0 0 0 182 35 Brisk Diffuse 16 13
R.S. 9 53 M Bus
conductor
3 0 0 0 0 0 132 9 Normal Diffuse 18 6
P.C. 10 38 F Shop
assistant








0 100 20 Brisk Diffuse 14 14






0 147 14 Normal Diffuse 16 16














































0 115 12.5 Brisk Diffuse 13 13
S.5*«K. 13 32 * kma 8 © 0 Supraa
H. Deltoid
0 124 20 rh>rual Diffuse 21 20
tf.T. 14 F oWoo
orksr
11 Weakness of ansa whoa
brushing hair. 11 0 0 0 114 20 dorsal Diffuse 14 13
T.C. 15 64 X BoilerPSMMi 2.5 Weakness of arms and
hands first, than
generalised.






























M«3* 14 5© y HOUSOWife 6 oakrasa of thighs.















0 131.5 23 Vernal Diffuse 15 15









































mm. Other pathology and
No. Yrs, lbs. R. U comments





























0 116.5 46 Normal Diffuse 14 12 Simultaneous onset
of Diabetes Mellitus
Ophthalmoplegia•
P.M. 20 39 F Civil Ser¬
vant




1.5 0 Biceps br.*
Trioeps*
0 144 21 Normal Diffuse 13 13










0 112 14 Dimin¬
ished
E.K. 22 38 M Faotozy
Supervisor













0 136 28 Brisk Diffuse 17 16























0 118 21 Normal
!
Diffuse 13 13






























25 55 « Elailaay
plate-
layer








C 149 Bomal Just
palpable
21 22 OpMtalsoplegitt









































29 53 P Shop
assistant

















0 112 18 normal "Meaoesa"
4. lobe
14 13
















31 50 F Housewife 6 0 0 0 0 0 122 18 Boreal Just
palpe.bie
13 15 Pernicious anaemia.
Diabetic for 11 yrs.
On insulin.
Ophthelapplegia •
M.S. 32 52 F
~
Tiautimlfe 4 0 0 0 Triceps* 0 109 16 B&mml Diffuse 15 15
E.U 33 28 ^aussgs
linker





0 156.5 im6 Brisk Diffuse 13 13


































J.T. 34 31 F Weayer 8 0 0 0 Left Deltoid*
L.Supraspin&tus*
Iliopsoas*
0 128 17 Brisk Diffuse 14 14
C.D. 35 15 F Unem¬
ployed
0.5 0 0 0 - 0 0 135.5 3 Normal Diffuse 18 16










J.L. 37 36 M Shipping
Agent
1.25 0 0 0 Left Triceps* 0 138 21 Brisk Diffuse 16 14 Ankylosing
spondylitis.













M.J • 39 25 W House¬
keeper
9 0 0 0 0 0 146 8 Normal Diffuse 17 15











0 132 35 Normal Ir¬
regular




E.W. 41 48 F Rayon
worker
3 0 0 0 L upraspinatus* 0 105 18 Brisk Diffuse 16 16
E.H. 42 53 F Shop
Asst.













0 98 27 Brisk Diffusa 14 14












0 82 29 Normal Diffuse 14 13
























































































0 111 9 Normal Diffuse 16 15
H.W. 46 67 F Housewife 3 0 0 Supraspinatua*
Infraspinatus*
0 0 141 35 Normal Diffuse 12 11
























0 119 21 Brisk Diffuse 11 9
B.B. 48 27 M Fitter 4 Loss of strength
in arms and legs.










0 163 42 Brisk Diffuse 17 17




































H.S. 49 42 H Timber
Cheoker
24 Legs and am# tired.



























0 104.5 7.5 normal Diffuse 16 15 Gynecomastia.













0 96 21 Brisk Nodular 10 10









0 155 8 Noraal Diffuse 12 12
k.S. 52 41 F i Housewife 9 0 0 0 Supraspinatus*
Deltoid*
L.Iliopsoae**
0 136 11 Brisk Diffuse 13 13
J.W. 53 64 F School"
teacher
3 0 0 0 Biceps br.*
Iliopsoas*

























































4 htm 24 hr. 48 hr.
1 50.0 67.5 67.1 23.4 Sinus tacJiyoardia. Left
ventricular hyp©rtnopby
112 9.6 14C 720
2 64.7 76.2 71.1 45.3 0.9 Slews tachycardia 90 10.1 250 1260
3 76.9 67.9 51.6 8.5 2.8 ;C laws tachycardia. Left
ventricular hypertrophy.
94 10.3 14 360 730
4 43.4 58.8 57.2 20.6 0.5 l .rjua tachycardia. Left
ventricular hypertrophy.
93 10.5 4.5 (40 1440




6 70.9 77.5 64.1 58.0 1 .36 Sinus tachycardia 108 9.7 3.7 340 1140
7 ♦22 atrial fibrillation 113 10.3 3.0 335 445
8 70.0 79.0 01.2 42.0 0.5 132, Sinus tachycardia 10.5 4.6 230 1070
9 73.5 88.7 72.0 10.6 115 9.5 44 530 1370
10 70.2 18.0 Sim# toohyoardia 90 9.7 4.9 800 860
11 86.0 78.0 68.0 21.5 OJS 9.7 Sinus tachycardia.
7 flat I, aVL and
chest leads.
104 , 10.5 3.0
12 75.0 77.5 74.1 51.2 13.1 9.7 4.4 431 504
13 90.6 84.4 77.6 71 <8 1*0 Sinus tachycardia 108 10.6 4.0 70 930
14 54.9 77.8 80.0 38.8 0.46 9.5 124 10.2 4.1 190 1095
15 95.0 86.5 85.0 1.27 13.3 Sinus tachycardia 90 10.0 3.8
16 94.4 67.9 50.4 44.7 4.32 Sinus tachycardia. Left
ventricular hyp^rtropby.
130 10.5 4.4 70 300
17 52.0 62.0 66.0 147.0 1.3 12.1 117 11.9 4.3
10 ♦ 48 7trial fibrillation 170 10.6 4.2 @0 1340











































atj./24hr.4 hr. 24 hr. 48 hr.
T index
19 70*9 78.5 68.8 46.5 11.3 Sinus taohyoardia 18.6
(Diabetic)
9.5 4.5 160 560
20 86.6 88.1 81.0 115.0 1.35 Sinus tachycardia
atrial ectopic®
100 4.4 240 330
21 76.1 83.1 75.0 1.7 ♦36 M.nue tachycardia. Left
veitrrcular hypertrophy.
9.C 4*5 300 860
22 79.0 40.5 31.8 14.3 3.05
■ | • 260 1420
23 44.5 64.0 63.0 16.8 0.15 12.6 finuc taohyoardia 95 3.7 380 1030
2^ 34.0 75.0 63.0 21 «8 2.1 10.7 trial fibrillation
Left ventricular
c:jyi>ertrophy.
78 9.4 fa# 110 1120
23 66.0 78.0 74.0 99.0 0.3 10.4 rinu® tachycardia 38 9.0 540 1760
26 68.4 92.0 88.0 33.0 0.65 9.5 finu® taohyoardia. Left
ventricular hypertrophy.
9.6 4.5 ■J




26 13-2 Sinus taohyoardia. Left
vCMtrieular hypertrophy.
94 9.3 4.9 330 770
23 79.0 82.0 74.0 53.0 1.8 11.6 Sinus tachycardia.
T aVL flat.
102 9.9 5.4 120 760
30 39.0 58.0 G6.G 32 J. 0.6 89.7 15.0 atrial flutter 94 10.0 4.5 960 50
31 46.0 63.0 63.0 0.65 ♦67 7.2 Sinus tachycardia Diabetic 10.6 5.0 590 1010
32 57.0 64.5 53.8 11.8 «j. <iVL 110 10.4 FA
33 53.9 70.5 69.5 53.5 0.46 Sinus taohyoardia 106 10.0 3.9
..
270 640
34 87.5 87.5 79.5 53.7 S3 Unus tachycardia. Left
vontrioular hypertrophy.
136 9.9 4.1 200 470
35 67.1 13.0 firaus tachycardia 110 103
f
4.2 120 300









































ag«/24hr«4 bar. 24 Itr. 48 hr.
36 57.6 +£4 8.9 Sinus tachycardia, left
veitrioular hypertrophy.
176 9.7 3.7 110 1060
37 46.0 61 .0 54.0 12.4 0.3 13.0 Sinus tachycardia.
Slight left ven¬
tricular hypertrophy.
125 10.5 4.5 180 1200
33 37.0 71.0 11.4 Siaus tachycardia. Left
ventricular hypertrophy.
128 10.6 4.0 35 990
39 84.1 Siaus tachycardia. Left
ventricular hypertrophy.
90 9.9 4.8 50 940
40 59.0 78.0 75.0 45.5 •f.16 11.0 SIbus tachycardia. Left
ventricular hypertrophy.
118 9.9 3.7 8 1000
if 34.8 71.0 62.0 40.5 4.2 6J4 Sinus tachycardia. Left
ventricular hypertrophy.
84 9.7 4.8 150 810
42 72.0 78.0 72.0 8.2 2.01 13.8 Left ventricular
hypertrophy.
9.9 3.9
43 90.0 84.5 77.0 31.5 2.0 15.0 Sims tachycardia 126 9.8 4.7 146 650




45 70.0 83.0 11.0 Sinus rhythm. S-T.
depression in II, III,
aVF
11.6 4.7 180 920
46 55.0 72.0 68.0 16.6 Sinus tachycardia. Left
ventricular hypertrophy.
112 10.2 4.2
47 68.5 81.5 75.5 6.65 Sims tachycardia 114 9.6 3.4 170 760
43 94.0 76.0 70.0 298.0 1.9 Sinus rhythm
Q aVL, flat T
130 10.1 4.2 90 680
49 66.0 40.0 21.4 21.3 3.8 Sinus tachycardia 80 9.4 3.3 50 1210
Appendix Table 2 continued
Case
m*






























4 bar. 24 hr. 43 hr.




120 10.3 4.3 35 690
51 74.9 B6.2 83.3 0.62 ♦37 Sinus tachycardia 108 9.5 4.0 510 1280
52 63.5 71.0 62.0 65.0 0.67 • "inus rhythm 100 1C.0 4.5 40 1220
53 70.5 76.8 74.0 19.4 0.5 I 14.'3 Atrial fibrillation 122 9.4 4.0 40 1270
54 64.0 84.0 76.0 228.0 0.9 14*6 Sinus tachycardia
: with bouts of
paroxysmal atrial
fibrill&tion ) •
110 10.3 4.6 315 945
Mmm mm i
Tim legs cotild be maintained in elevation by thyrotoxic
patients before and after edrophonium ( Tensilon).
Leg raising (average of both legs) seas*
Case
No*





















The patients Eleotrornyogtnphy bet03 e and after treatment































































1 42 R. Belt. 208 24 8.7 4220 24 175 6 20.0 0 0 0 I.P. 244 25 9.7 3290 24 137 1 3.8 0 0 0
2 48 K. Root, Fesa .267 33 8,1 4880 33 148 5 13.2 0 0 0 I.P.
.... 3i
< . • -
489 37 13.2 5570 37 150 5 11.9 0 0 0 I.P.
3 25 R.frloepa 156 20 7.8 2270 20 113 8 28.6 0 0 0 I.P. 424 40 10.6 5070 39 130 5 11.1 0 0 0 I.P.
4 47 P.. Belt, 175 20 8.8 3100 20 155 6 23.1 0 0 0 I .P. 418 35 11.9 4370 35 125 5 12.5 0 0 0 I.P.
5 60 R.R@ct.Fasa. 222 26 8.5 4160 26 160 3 10.3 0 0 0 I.P. 585 44 13.3 6610 44 150 9 16.9 0 0 0 I.P.
6 22 R .Root.Fern. 192 22 8.7 4350 21 207 7 24.1 0 0 0 i.p. 529 39 13.6 4330 37 117 6 13.3 0 0 0 I.P.
7 57 R.R©ct.Fen« 222 22 10.1 2630 22 119 4 15.4 0 0 0 1.p. 381 36 10.6 4360 36 135 1 2.7 0 0 0 I.P.
8 37 RJieot«i'ea. 370 31 11.9 8060 29 278 «oaCO 0 0 0 i.p. 501 34 14.7 5520 34 162 0 0 0 0 0 IJP.
9 53 R.iectaFeti. 278 26 10.7 17720 36 492 5 16.1 0 0 0 i.p. 682 46 14.8 5560 46 123 4 8.0 0 0 0 I.P.
10 33 H• Belt• ,163 22 7Jk 1990 21 95 6 21.4 0 0 0 i.p. 355 32 11.1 3420 31 110 6 15.8 0 0 0 I.P.
11 50 R. Belt, 261 33 7.9 4520 33 137 3 8.3 0 0 0 i.p. 285 23 12.4 2780 23 121 12 34.3 0 0 0 I.P.
12 48 Pa Belt, 190 25 7.6 6370 26 245 10 28.6 0 0 0 i.p. 466 37 12.6 5860 36 162 9 19.6 0 0 0 I.P.
13 32 R. Delta 196 27 7.3 5580 35 159 5 15.6 0 Fib.x 1 0 i.p. 629 51 12.3 5290 51 104 4 7.3 0 0 0 IJP.
14 26 L. Delta 183 22 8.3 3960 20 198 5 18.5 0 0 0 i.p. 342 32 10.7 8500 29 293 3 8.6 0 0 0 I.P.
15 64 Pa Delta 221 23 9.6 2050 23 89 17 42.5 0 0 0 i.p.





r» - ■ ; - V
510 35 14.6 5430 35 155 2 5.4 0 0 0 I.P.
17 69 La Delta 30? 40 7.5 4900 40 122 10 20.0 0 B iscacxl 0 I.P. 650 56 11.6 17060 56 305 6 9.7 0 0 0 I.P.
























449 40 11.2 4070 40 102 4 9.1 0 0 0 X.P.
19 66 Ra Delta 187 25 7.5 2730 25 109 11 30.6 0 0 0 I.P. 405 33 12.3 3540 33 107 5 13.2 0 0 0 I.P.
20 39 Ra Delta 212 30
*
7.1 4850 30 162 4 11.8 0 0 0 i.p. 281 23 12.2 2540 23 110 6 20.7 0 0 0 I.P.
Appendix Table 4 continued*






























































21 70 L.Reet. Fon * 263 j* a.a 4550 29 157 7 18.9 0 0 0 I.P. 502 36 13.9 4980 36 138 5 12.2 0 0 0 I.P.
22 38 R. Belt, 268 32 8*4 6250 32 195 4 11.1 0 0 0 I.P. 534 41 13.0 6100 40 152 8 16.3 0 0 0 I.P.
23 53 L*Rect* Fern* 367 35 10*5 5950 35 170 7 16.7 0 0 0 I.P.
R.Ab.Dig.V 463 42 11.0 5580 41 137 4 8.7 0 0 0 I.P.
24 56 R # Belt* 210 27 7.8 2510 27 100 6 18.2 0 0 0 I.P.
R*Ab.Dig.V 215 25 8.6 2340 25 94 7 21.9 0 Fascic.
x 7
0 I.P.
25 55 R. Delt* 293 31 9.5 2850 30 95 5 13.9 0 0 0 I.P. 321 24 13.4 3470 24 145 1 4.0 0 0 0 I.P.
R«Ab.Dig.V 326 54 6*0 7940 49 162 6 10.0 0 Fascic.
x 1
0 I.P.
26 52 R# Delt* 321 41 7*8 3080 40 77 9 18.0 0 0 0 I.P.
R.Ab.Dig.V 221 33 6.7 4970 32 155 5 13.2 0 0 0 I.P.
27 55 R*Rect*Fem* 284 26 10.9 3360 26 129 3 10.4 0 0 0 I.P. 386 32 12.1 4460 31 144 4 11.1 0 0 0 I.P.
28 35 R. Delt* 141 21 6.7 2696 21 128 8 27.6 0 0 0 I.P.
29 53 R* Delt* 183 23 7.9 1990 23 86 11 32.3 0 0 0 I.P. 372 32 11.6 3870 32 121 6 I5.8 0 0 0 I.P.
R.Abd.Dig.V 195 33 5.9 5510 31 178 6 15.4 0 Fib.x 1 0 I.P.
30 49 L* Belt* 227 25 9.1 2280 25 115 3 10.7 0 0 0 I.P. 388 33 11.6 4^50 33 135 2 5.7 0 0 0 I.P.
L*Ab*Dig.V 331 39 8.5 4490 36 125 10 20.4 0 Fib.x1 0 I.P.
31 50 R* Delt* 272 25 10.9 3810 25 152 7 21.9 0 0 0 I.P. 435 36 12.1 4240 36 118 4 0.0 0 0 0 I.P.
R.Ab.Dig.y 481 46 10.5 5900 46 128 8 14.8 0 Fascic.
x 1
0 I.P.
32 52 R. Delt. 253 24 10.5 2900 24 120 8 25.0 0 0 0 I.P. 408 36 11.3 4470 35 128 6 4.3 0 0 0 I.P.
R*Ab*Mg.V 279 30 9.3 3860 30 129 7 18.9 0 0 0 I.P.
33 28 I» .Root *Fem * 138 20 6*9 2060 20 103 4 16.7 0 0 0 I.P.
Appendix fable 4 continued.


































































34 31 R .Rent .Fes. 426 43 5.5 2280 41 70 & 16.3 0 0 0 I.F. 298 24 12.4 216C 24 90 8 25.0 0 0 0 I.P.
E.Ab.Dig.T 274 38 7*2 3550 36 99 6 13.6 0 0 e I.P.
35 15 R. Deli. 352 45 7*k 5290 45 117 9 16.7 0 0 0 I.P.
56 48 E.Eeot.Pmu 357 56 9.9 3010 34 88 5 12.2 0 0 0 * I.P.
H.Ab.Dig.V 178 24 7.4 2070 24 86 7 33.3 0 0 0 I.P.
37 56 B. Pelt. 323 32 10.1 2180 32 68 13 28.9 0 0 0 I.P. 411 35 11.7 2860 35 82 2 5.4 0 Fib.xl 0 I.P.
R.Ab.Dig.V 267 39 6.8 5610 39 144 4 9.3 0 0 a I.P.
38 53 L. Deli. 178 31 5.7 3550 30 118 2 6.1 0 0 0 I.P. 412 42 9.8 3520 42 83 6 12.5 0 0 0 I.P.
59 25 ■' .Moot/ »i cut. 225 22 10.2 2380 21 142 5 18.5 0 0 0 I.P. 370 33 11.2 3190 33 9? 1 2.9 c 0 0 I.P.
40 63 H •! .ooi»t?e®. 639 59 10.8 8140 56 145 7 10.6 0 0 0 I.P.
R.Ab.Mg.V 634 80 7 *b 14370 78 184 8 9.1 0 0 0 I.P.
M 48 R .Reot .Fern. 391 47 8.3 5320 47 113 4 7.8 0 0 0 I.P. 499 38 13.1 4010 38 105 3 7.3 0 0 0 I.P.
R.Ab.Dig.V 366 58 6.3 6910 56 123 6 9 J* 0 0 0 I.P.
42 53 R JRe)t»P®#. 480 59 8.1 6370 53 110 9 13.2 0 0 0 I.P.
R.Ab.Dig.f 556 46 7.3 4410 46 96 4 3.0 0 0 0 I.P.
45 60 R .Rest .Pern. 357 45 7.9 3690 44 84 11 19.6 0 0 0 M.P. 382 27 14.1 2070 27 77 7 20.6 0 0 0 I.P.
44 62 R (RsottFei* 304 34 8.9 3320 34 95 3 19.0 0 0 0 M.P. 389 32 12.2 2110 32 66 5 13.3 0 0 0 I.P.
R.Afe.»ig.V 282 43 8.? 6550 41 160 4 0.5 0 0 0 I.P.
45 55 4• Delt• 570 49 11.6 10190 49 208 8 14.0 0 0 0 I.P. 349 30 11.6 3520 30 117 4 11.8 0 0 0 I.P.
Iv.Ab J5ig.V 432 49 3.8 4050 49 83 13 20.9 0 0 0 I.P.
Appendix Table 4 continued.
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46 67 RJReot.Fea. 553 52 10.6 7690 51 151 8 13.3 $ 0 0 I.P.
*
R.Ab.Dig.V 492 67 7.3 6710 64 105 9 11.5 0 Fib.x1 0 TJ>.
47 40 R.Reot.Fem. 517 46 11.2 8720 44 198 7 13.2 0 C 0 I.P. 373 25 15.0 3970 25 159 1 3.3 0 0 0
48 27 R« Belt. 398 52 7.6 5580 52 107 10 16.1 0 0 0 I.P.
R.Ab.Dig.V 239 33 7.2 5080 32 159 3 8.3 0 0 0 I.P.
49 42 R. Delt. 264 32 8.2 2650 31 85 4 11.1 0 0 0 I.P.
R*Ab«Dig.V 286 36 7.9 4430 35 127 4 *0.C 0 0 0 I.P.
50 69 R. Delt. 188 21 8.9 2010 21 96 8 27.6 0 0 0 IJ».
51 39 H .Root tF em . 497 46 10.8 6910 46 150 3 6.1 0 0 0 I.P.
52 41 R.Peot.F©ri. 438 40 10.9 4870 38 128 7 14.9 0 0 0
53 64 R. Delt. 399 44 9.1 4210 44 96 10 13.5 0 0 c I.P.
R.Ab.Dig.V 325 58 5.6 7190 56 128 4 6.4 0 0 0 I.P.
54 60 R .Rect.Fem. 394 46 8.6 4060 45 90 10 17.9 0 0 0 I.P.
I.P. * Interference pattern
M.P. « Mixed pattern
Appendix Taole 5
Control electronjyograms: Deltoid.
No. Age Sex Condition























1 27 M Normal 335 31 10.8 2380 31 77 4 11.4 0 0 0 I.P.*
2 49 F Myocardial infarct 404 34 11.9 3260 34 96 4 10.5 0 0 0 I.P.
3 43 M
'
Normal 492 37 13.3 1930 24 80 5.1 0 0 0 I.P.
4 43 M Normal 259 20 12.9 1930 20 96 3 13.0 0 0 0 I.P.
5 67 F Hiatus hernia 433 34 12.7 2970 34 87 7 17.1 0 0 0 I.P.
6 71 M Myocardial infarct 261 30 12.0 2850 30 95 7 18.9 0 0 0 I.P.
7 35 F Thyroid cyst 487 45 10.8 5570 ,45 124 1 .2*2 0 0 0 I.P.
8 32 Hi Normal 360 33 11.0 5190 33 157 4 10.8 0 0 0 I.P.
9 38 M Renal glycosuria 428 36 11.9 3110 36 86 3 7.7 0 -N 0 0 I.P.
10 72 F Myocardial infarct 461 37 12.5 4590 37 124 4 9.8 Fib. x 2 0 0 I.P.
11 60 M Cholecystitis 488 35 13.9 4110 35 117 2 5.4 Fib. x 1 0 0 I.P.
12 74 M Myocardial infarct ,506 38 13.3 3470 36 96 6 13.6 0 0 0 I.P.
13 54 F Stokes Adams attacks 561 42 13.4 3360 42 80 5 10.6 0 0 0 I.P.
14 21 F Normal 376 30 12.5 2530 30 84 1 3.2 0 0 0 I.P.
15 66 M Normal 576 47 12.3 5820 47 124 4 7.8 0 0 0 I.P.
16 20 F Normal 430 35 12.3 3520 35 100 4 10.3 0 0 0 I.P.
17 23 M Normal 322 28 11.5 2940 28 105 4 12.5 0 0 0 I.P.
18 22 M Normal 336 29 11.6 5010 27 186 1 3.3 0 0 0 I.P.
19 19 M Normal 242 23 10.5 4310 23 187 2 8.0 c 0 0 I.P.
20 27 M Normal 325 31 10.5 4620 31 149 3 8.8 0 0 0 I.P.
21 21 M Normal 409 39 10.5 4250 39 110 5 11.4 0 0 0 I.P.
■*




















Control j&eotremyog roast leotus I'eaoris
S©* Condition




















X Strop* pharyngitis 342 29 11.8 26-90 29 93 2 6.5 0 0 0 1,9,*
F Myocardial iafarot 385 29 13.3 1830 2) 176 1 3.3 0 0 0 I.P.
X :4y ^cardial infarot 397 28 14.2 8820 27 327 2 6.7 0 0 0 I.P.
F Myocardial infarct 352 26 13.5 2510 26 53 3 10.5 0 0 0 I.P*
F iai-oaysaal arrfcythala 422 30 14.1 8430 31 283 3 9.0 0 0 0 I.P.
1! yooerdlal infarct 330 25 12.8 4370 25 195 1 3.8 0 0 0 I.P.
X chronic bronchitis 357 25 14.3 23 87 2 7.4 0 0 0 I.P.
X Duodenal uleer 6*5 48 13.9 4810 43 142 6 11.1 0 0 0 I.?.
X "yeoardial infarct 282 20 14.1 3190 20 159 1 4.8 0 0 0 I.P.
X Stomal 581 40 14.5 2670 30 89 5 11.1 0 0 0 I.P.
? Xomal 236 20 11.8 1970 17 116 3 13.0 0 0 0 I.P.
F Stomal 430 36 11.9 4350 34 143 3 7.7 0 0 0 I.?.
X Stomal 432 36 13*4 5040 36 V 0 5 12.2 0 0 0 I.P.
X Nerval 425 31 15.8 4530 30 153 4 11.4 0 0 0 Id9.
X HMMI 481 37 13.0 7640 37 206 0 0 0 0 0 I.P.
X Nersal 274 25 11.0 4950 23 171 6 17*1 0 0 0 I.P.
s Formal 241 21 11.5 2690 21 128 j 1 4.5 0 0 0 I.P.
♦T.r>. * Interference pattern.
APPENDIX TA.3LS 7
Electromyogra'S: Peak to peak voltage of the interference
pattern on maximal effort.
Deltoid Reotus Femoris





















11 - .4 11 3.8 1 3.3 2 0.9 2 2.8 1 7.0
30 2.6 12 3.8 2 3.7 5 1.6 4 7.3 2 3.5
35 2.1 13 1.0 5 3.8 7 2.1 5 2.7 3 6.5
57 3.7 14 8.2 6 5.7 16 1.6 6 3.3 4 6.0
45 3.4 17 4.0 8 5.8 34 2.4 7 2.9 5 5.3
48 4.1 18 5.0 9 7.5 36 3.3 8 7.8 6 6.0
49 5.3 19 4.0 10 3.2 39 3.8 10 6.7 7 4.3
50 4.0 20 5.3 11 3.8 40 3.1 16 4.0 8 4.3
53 5.3 22 3.5 12 3.0 41 4.3 21 2.5 9 2.5
29 3.5 13 4.0 42 2.4 27 3.2 11 1.7
30 3.8 14 7.7 43 1.7 34 3.5 12 1.9
31 5.2 15 4.8 44 3.3 39 2.5 13 4.7
32 5.0 16 4.7 46 2.3 41 4.0 14 3.0
37 4.8 17 6.0 47 3.0 43 3.8 15 8.3
38 2.7 19 2.7 51 4.5 44 2.0 16 1.9
45 4.7 54 1.1
APPENDIX TABLE 8
Control Electrcssyograias: Abductor digit! quinti
Ho* AgO >ex Condition





















1 32 F Pneumonia 326 32 10.2 4,960 32 155 5 13.5 0 0 0 I.P.*
2 43 M Normal 288 38 7.6 4,050 37 109 6 15.6 0 0 0 I«P*
3 21 F Normal 377 38 9.9 4,170 33 110 4 9.5 0 0 0 I .P.
4 23 M Nomal 325 41 7.9 6,320 33 166 8 16.3 0 0 0 I.P.
3 22 M Normal 271 50 9.0 3,920( 29 135 4 11.7 0 0 0 I.P.
6 71 M Myocardial infarct 378 39 9.7 3,774 37 102 7 15.9 0 0 0 I.P.
7 68 M Myocardial infarct 305 27 11.3 3,361 27 143 3 10.0 0 0 0 I.P.
8 57 F Poptio uloer 273 29 9.4 6,757 29 233 2 6.5 0 0 0 I.P.
9 55 M Myocardial infarct 266 28 9.5 2,800 28 100 3 9.7 0 0 0 I.P.
10 42 F Cholecystitis 409 47 3.7 16,200 45 360 3 6.2 0 0 0 I.P.
11 43 M Myocardial infarct 286 34 8A 5,066 34 149 1 2.9 0 0 0 I.P.
12 26 M Normal 535 50 10.7 6,600 50 132 4 7.4 0 a 0 I.P.
13 65 F Myocardial infarct 331 38 8.7 4,484 ' 38 118 4 9.5 0 0 0 I.P.
14 27 F Nomal 336 40 8.4 6,340
1
40 171 5 11.1 0 0 0 I.P.
15 55 F Cholecystitis 515 56 9.2 6,490 55 118 9 14.1 0 0 0 I.P.
16 29 F Nomal 353 42 8.4 10,500 42 250 4 8.7 0 0 0 I.P.
17 64 M Myocardial infarct 270 27 10.0 2,970 27 110 2 6.9 0 0 0 I.P.
18 37 F Urinary tract infection 391 38 10.3 4,826 38 127 2 5.1 0 0 0 I.P.
•T.P. s Interference Pattern.
APPENDIX TABLE 9
Ulnar Nerve: Latenoies and Conduction Velocities


















1 32 Pneumonia 3.2 52.1 41 48 2.25 96.5
2 43 Normal 2J0 64.1 42 53 3.8 79 .4
3 21 Normal 3.4 64.3 43 60 2.5 47.3
4 23 Normal 2.8 65.2 44 62 2.4 63.9
5 22 Normal 2.5 47.6 45 55 2.7 67.7
6 71 Myocardial
infarct
2.3 67.8 46 67 2.3 50.9
7 26 Normal 2.3 72.6 47 40 2.25 51.2
8 68 Myocardial
infarct






















2.3 69.7 53 64 2.3 58.7




14 38 Normal 2.6 57.5
15 29 Normal 3.4 53.3
APPENDIX TABLE 1"









































42 F Carbimazole, iodine and thyroidectomy 2
. ■jtsr"Y
0 0 8.0 95 880 10 10 ♦ 2.0
2 MS F Radioactive iodine 4 1 4 12.5 30 960 21 19 ♦ 2.5
3 25 F Carbimazole and 1-thyroxine 2 1 1 12.0 270 1230 12 11 + 1.5
, 4 47 M Radioactive iodine 5.5 0 0 13.0 18 820 15 14 - 0.5
5 60 F Two doses of radioactive iodine,
one month's Carbiaazole after eaoh.
6 0 0 12.0 129 771 15 15 0
6 22 F Carbimazole and 1-thyroxine 1.0 1.0 4 12.0 90 875 14 13 - 1.5
7 57 F Carbimazole, guanethidine, iodine and
thyroidectomy.
0.5 2 5 6.5 16 16 - 2.0
8 37 M Carbimazole, then Pot. perchlorate,
thyroidectomy.
3 0 0 28.0 50 1000 16 14 + 0.5
9 53 M Radioactive iodine 4 0 0 13.0 60 1420 19 17 + 1J3 -
10 38 F Carbiraazole, 1-thyroxine, iodine and
thyroidectomy.
2.5 2.5 4.75 120 1130 14 14 0
11 50 F Radioactive iodine 4 4 17.0 60 1410 17 16 + 0.5
12 48 F Radioactive iodine 3.25 3.25 3.25 0 232 1088 14 14 + 1.0
13 32 M Carbimazole, 1-thyroxine, iodine and
thyroidectomy.
1 0 1 10.0 to 17 . 2.0
14 26 F Carbimazole and 1-thyroxine - 3 0 0 5.0 40 1125 16 14 + 1.5
15 64 M One dose of radioactive iodine,
followed by Carbimazole for one
month.Remission for 3 months, then
relapse, treated insimilar fashion.
3 3 3 41.5 14 14 + 0.5
16 50 F Radioactive iodine and Carbiraazole
for one month.
1 3 3 16.5 20 1210 15 14 - 0.5
17 69 F Radioactive iodine and Carbimasole
for 6 weeks.
2.5 2.5 2.5 12.0 24 762 15 16 + 1.5








































18 64 M Carbimazole, 1-thyroxin®, iodine
and thyroidectomy.
1.5 1.5 0 41.0 100 1720 17 17 ♦ 1.0
19 66 F Radioactive iodine 3 3 3 248 821 16 13 ♦ 1.5
20 39 F Carbimazole, 1-thyroxine, iodine,
thyroidectomy.
2 2 0 31.0 50 143® 14 13 + 0.5
21 70 F Carbimazole, 1-thyroxine 1.75 1.75 1.75 15.0 114 775 15 12 ♦ 1.5
22 33 M Carbimazole, 1-thyroxine, iodine,
thyroidectomy.
3 1 6 18.5 17 16 0
23 53 F Radioactive iodine 4 0 0 18.0 14 12 + 2.0





1.5 18.0 18 18 ♦ 5.0
25 55 K Carbiraazole, 1-thyrexine 1.75 0.75 0 12.0 20 1726 22 23 ♦ 1.0
26 52 F RacLioaotive iodine 2 2 2
27 55 M Radioactive iodine 0 21.0 60 1640 13 12 ♦ 1.5
28 35 F Carbtmazole, 1-thyroxin®, iodine,
thyroidectomy.
3 1 3
29 53 F Radioactive iodine and Carbimazole
for 7 weeks.
0.75 3 0.75 36.0 57 1040 - 13 13 - 0.5
30 49 M Radioactive iodine and Carbiaazole
for 2 months.
2 2 2 21.0 40 1430 14 16 0
31 50 F Carbimazole, 1-thyroxine 0.75 0 0 20.0 38 946 16 18 ♦ 3.0
32 52 F Radioactive iodine, oarbimazole
for one month.
1 1 0 17.0 24 1008 15 15 0
33 28 F Carbimazole, 1-thyroxine 4 4 0 7.5 15 15 + 2.0
34 31 F Carbimazole, 1-thyroxine 1.5 1.5 0 6.0 12 12 - 2.0
35 15 F Carbimazole, 1-thyroxine 1 0 0 15.0 19 18 + 1.5
36 48 F Radioaotive iodine
i
2.75 5 0 11 11 - 0.5












































57 56 M Carbiraazole, 1-thyroxine, iodine,
thyroidectomy.
5-75 3.75 0 17.0 40 1190 17 16 ♦ 1.5
58 58 F Radioactive iodine and oarbimazole
for one month
1 3.5 3.5 10.0 66 1067 16 13 ♦ 2,0
59 25 F Carbiraazole, 1-thyroxine 1 0 0 11.0 56 964 17 15 ♦ 1.0





48 F Radioactive iodine and oarbimazole
for six weeks
1 1 0 19.0 310 1420 17 16 * 0.5
42 55 F Radioactive iodine and oarbimazole
for six weeks. Relapse one month
later.
1 1 2
45 60 F Radioactive iodine and oarbiaazole
for one month.
1 4.25 2 19.0 64 783 15 14 •f 1.0
44 62 F Radioactive iodine and carbimazole
for one month.
1.5 3 3 13.0 23 22 0
45 55 F Radioactive iodine and oarbimazole
for one month.
1.25 1.25 5 16.5 90 1230 18 16 ♦ 1.5
46 67 F Radioactive iodine and oarbimasole
for one month.
1 0 1 20.0 14 14 ♦ 2.5
47 40 F Carbimazole, 1-thyroxine, iodine
and thyroidectomy•
1.25 2.25 1.25 21.0 50 1130 12 11 ♦ 1.5
48 27 V Carbiraazole, 1-thyroxine, iodine
and thyroidectomy.
2 2 2 57.0 16 16 - 1.0
49 42 M Carbimazole Being treated pri rately.
50 69 F Carbimazole, iodine, thyroidectomy.
Atrial fibrillation removed with
D.C. de-fibrillator.
1.25 4 4 6.0 12 10 ♦ 1.0
51 59 F Carbimazole, 1-thyroxins 1.5 1.5 0 -
52 41 F Carbimazole, 1-thyroxine 1 1 0 15 15 * 2.0
55 64 F Radioactive iodine, oarbimasole
for 7 weeks. Atrial fibrillation
oonverted with. D.C. de-fibrillator.
2 1 0




Data en the extent of muscle involvement in thyrotoxicosis,
weight loss and the deviation of the observed mean action
potential duration firm the predicted#
Atrophy and/or weakness
Proximal and ircximsl
distal muscles muscles only
I'tOlAI?
Case t# ffovia* Case wi# Devia¬ '.vt. devia¬
No# less tion No# loss tion NO. loss tion
lb. s.seo. lb. sucec# lb. ra.sec.
6 18 3.5 2 18 5.1 1 7.5 3.3
7 19 3.5 3 7 2.S 4 3 3.4
13 19 3.5 10 20 4.4 5 14 3.2
19 46 5.7 11 14 4.5 8 35 0.9
24 21 4.9 12 12.5 4.7 9 9 2.7
28 32 5.0 13 20 4.2 14 20 2.9
43 29 5.8 16 23 3.5 23 6 2.9
44 9 4.9 17 16 5.8 31 18 1.5
47 21 1.7 18 13 4.5 35 3 3.3


























Deltoid and .Rectus femoria
Deviations of the observed mean action potential
duration fro® the predicted in thyrotoxic patients




Deviation m. 3ec. Deviation m. sec.
Case Weakness Case Weakness Case Weakness Case Weakness
No. present No. absent Ne. present No. absent
10 4.4 1 3.3 2 5.1 5 5.2
11 4.5 4 3.4 6 3.5 8 0.9
12 4.7 13 4.2 7 3.5 9 2.7
15 3.5 14 2.9 21 5.3 23 2.9
17 5.8 20 4.8 43 5.8 27 2.6
18 4.5 22 3.4 28 5.5
19 5.7 25 3.1 34 2.6
24 4.9 26 4.7 36 3.3
28 5.0 31 1.5 39 2.1
29 4.6 32 2.0 40 3.1
30 3.2 35 3.3 41 4.9
38 7.1 37 1.6 42 5.3
45 1.0 48 3.7 46 3.4
49 3.8 53 4.0 47 1.7





Relationship between serum protein bound iodine and
the deviation of the observed mean action potential









































Rectus femoris: Thyrotoxic patients
Data on duration of thyrotoxicosis, weight loss and
the deviation of the observed mean action potential














2 48 4.0 18 5.1
5 60 2.0 14 5.2
6 22 12.0 18 3.5
7 57 20.0 19 3.5
8 37 12.0 35 0.9
9 53 3*0 9 2.7
16 50 8.0 23 3.5
21 70 3.0 14 5.3
23 53 4.0 6 2.9
27 55 5.0 6 2.6
33 28 1.25 6 5.5
3k 31 8.0 17 2.6
36 48 4.0 5 3.3
39 25 9.0 8 2.1
40 65 4.0 35 3.1
41 48 3.0 18 4.9
42 53 6.0 27 5.3
43 60 5.0 29 5.8
kk 62 7.0 9 4.9
46 67 3.0 35 3.4
47 40 12.0 21 1.7
51 39 9.0 8 2.0
52 41 9.0 11 2.0
54 60 24.0 32 5.1
IBBBg table 12
Deltoid: Thyrotoxic Patients
Data on duration of thyrotoxicosis, weight loss and the

















1 42 I 7.5 3.3
4 47 1.75 3 3.4
10 38 8 20 4.4
11 50 6 14 4.5
12 48 6 12.5 4.7
13 32 8 20 4.2
14 26 11 20 2.9
13 64 2.5 19 3.5
17 69 2 16 5.8
18 64 3 13 4.5
1S 66 4 46 5.7
20 39 8 21 4.8
22 38 5 28 3.4
24 56 3 21 4.9
25 55 12 0 3.1
26 52 1.5 18 4.7
28 35 3 32 5.0
29 53 1.75 18 4.6
30 49 4 21 3.2
31 50 6 18 1.5
32 52 4 16 2.0
35 15 0.5 3 3.3
37 36 1.25 21 1.6
38 58 4 17 7.1
45 55 11 9 1.0
48 27 4 42 3.7
49 42 24 7.5 3.8
50 69 24 21 4.4
53 64 3 9 4.0
